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Abstract 
Previous studies have demonstrated that the para ventricular nucleus of the 
thalamus (PVT) receives heavy projections from numerous hypothalamic peptides 
involved in energy homeostasis and brainstem monoamines involved in various 
aspects of stress and arousal. Not surprisingly, the PVT is highly active during 
periods of active waking as well as stress and lesions of the PVT influence feeding 
behavior and anticipatory reactions to cues signaling food reward. Furthermore, the 
PVT sends a dense glutamatergic projection to the same regions of the nucleus 
accumbens shell (NacSh) receiving heavy dopaminergic innervation from the ventral 
tegmental area. Although numerous cortical afferents to the accumbens have been 
shown to mediate a glutamate-dependent regulation of dopamine efflux within the 
NacSh, little is known regarding the role ofPVT terminals within this region of the 
ventral striatum. Initial anatomical experiments were done to examine the 
innervation of the PVT and adjacent thalamic nuclei by two recently discovered 
hypothalamic peptides termed the orexins and cocaine and amphetamine related 
transcript (CART), both of which have been heavily implicated in stress and arousal 
as well as energy homeostasis. Specifically, orexin and CART peptides fibers were 
investigated in terms of their relationship and proximity to PVT neurons projecting to 
the NacSh. Further experiments were done using in vivo voltammetry to examine the 
effects of electrical stimulation of the PVT on dopamine efflux in the NacSh. The 
PVT was found to receive heavy projections from both orexin immunopositive and 
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CART immunopositive fibers whereas adjacent thalamic nuclei received considerably 
less or no innervation whatsoever from either peptide. Orexin and CART fibers in 
the PVT were found to co-express immunoreactivity for synaptophysin, a marker for 
presynaptic exocytotic release, suggesting that these neuropeptides are actively 
released within the PVT. High magnification confocal and light microscopy revealed 
frequent appositions between orexin and CART fiber varicosities and PVT neurons 
projecting to the NacSh. Voltammetric recordings from the NacSh demonstrated that 
brief electrical stimulation of the PVT (400 J,LA, 40Hz, 1.0 ms for 5s) resulted in a 
transient increase in dopamine oxidation current within the NacSh. The PVT -evoked 
response was found to be insensitive to inhibition of midbrain dopamine neurons, 
suggesting a presynaptic regulation of dopamine release. Indeed, an immediate 
attenuation of PVT evoked dopamine transients was observed upon intra-accumbens 
infusion of the ionotropic glutamate receptor antagonist kynurenic acid. It is 
hypothesized that this hypothalamic-thalamic-striatal circuit is important in the 
facilitation of specific motivated behaviors and is discussed in terms of both a stress 
and arousal induced increase in dopamine efflux as well as a dopaminergic 
modulation of food-seeking behavior. 
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Chapter 1 
Introduction 
1.1 The midline and intralaminar thalamus 
The midline and intralaminar thalamus was introduced as a group of diencephalic 
nuclei that collectively formed part of an ascending reticular activating system 
contributing to general cortical arousal (Groenewegen & Berendse, 1994; VanderWerf 
eta/., 2002). An extensive relay role for these thalamic nuclei was suggested by early 
tract tracing studies revealing widespread cortical afferents originating from neurons 
throughout the midline and intralaminar thalamus (Royce et a/., 1989). However, recent 
investigations using more sensitive tract tracing techniques have demonstrated that the 
individual thalamic nuclei within this complex project to distinct cortical and subcortical 
forebrain areas (Bubser & Deutch, 1998; Moga et a/., 1995; Su & Bentivoglio, 1990; Van 
der Werf et al., 2002). Research has since been directed at anatomically and functionally 
defining each individual nucleus within the midline and intralaminar thalamus. A recent 
review (VanderWerf eta/., 2002) separates the midline and intralaminar nuclei into four 
groups based on their efferent projection patterns (Fig 1.). First, the awareness of 
viscerosensory stimuli is attributed to a dorsal group that includes the paraventricular, 
paratenial, and intermediodorsal nuclei and their projections to the ventral striatum, 
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Fig. 1. Schematic diagram highlighting the locations and projections of three of the four 
"groups" of midline and intralaminar nuclei as proposed by Van der Werf (2000). 
Numbers indicate approximate distance from bregma. 3V, third ventricle; ACM, anterior 
central medial nucleus; CL, central lateral nucleus; fr, fasciculus retroflexus; IMD, 
Intermediodorsal nucleus; PC, paracentral nucleus; PCM, posterior central medial 
nucleus; PT, paratenial nucleus; Re, nucleus reunions; Rh, rhomboid nucleus; sm, stria 
medullaris. 
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-1 50 mm 
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Dorsal Group projects to: 
-Ventral Striatum 
-Amygdala 
-Pre- and lnfralimbic Cortex 
Lateral Group projects to: 
-Dorsal Prefrontal Cortex 
-Dorsal Striatum 
-Cingulate Cortex 
Ventral Group projects to: 
-Hippocampus 
-Primary Motor Cortex 
-Primary Sensory Cortex 
-Association Cortical Areas 
• Posterior Group (not shown) 
projects to: 
-Caudate and Putamen 
-Globus Pallidus 
-Substantia Nigra 
-Subthalamic Nucleus 
amygdala, and the pre- and infralimbic cortices. Second, a lateral group that includes the 
paracentral, central lateral and anterior central medial nuclei, plays a role in cognitive 
awareness via projections to the dorsal striatum and cingulate cortex. Third, the reuniens, 
rhomboid and posterior central medial nuclei make up a ventral group that projects to 
non-limbic cortical regions and is involved in polymodal sensory awareness. Last, a 
posterior group involved in the generation of motor responses to stimulus awareness 
includes the centre median and parafascicular nuclei and projections to the sensory and 
motor cortices. An overview of these thalamic groups can be seen in Figure 1. Of interest 
to the present experiments is the dorsal group, in particular, the paraventricular nucleus of 
the thalamus (PVT) and its heavy glutamatergic projection to the shell of the nucleus 
accumbens (NacSh). 
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1.2 The Paraventricular Nucleus of the Thalamus (PVT) 
1.2.1 Afferents of the PVT 
The PVT is a small nucleus within the midline and intralaminar complex. 
Located on the midline immediately ventral to the third ventricle, the PVT is thought to 
contribute to forebrain arousal and awareness by receiving a wide array of arousal-related 
information from the brainstem and hypothalamus (Groenewegen & Berendse, 1994; Van 
der Werf eta/., 2002). The PVT receives projections from nociceptive and visceral 
relays in the brainstem including the periaqueductal grey, parabrachial and solitary tract 
nuclei (Chen & Su, 1990; Cornwall & Phillipson, 1988; Krout eta/., 2002; Krout & 
Loewy, 2000a, 2000b; Ruggiero eta/., 1998). Hypothalamic areas involved in stress and 
arousal as well as homeostatic and circadian regulation also heavily innervate the PVT 
(Cornwall & Phillipson, 1988; Kirouac eta/., 2005; Novak eta/., 2000a; Otake, 2005; 
Otake & Ruggiero, 1995; Parsons eta/., 2006). In general, the innervation patterns found 
within the PVT are unique compared to other midline and intralaminar nuclei. For 
example, the PVT can be distinguished from adjacent nuclei based on a dense innervation 
by norepinephrine fibers originating in the locus coeruleus (B. E. Jones & Yang, 1985) 
and serotonin fibers likely originating from the dorsal and median raphe (Freedman & 
Cassell, 1994; Krout eta/., 2002). Arousal and feeding related peptides such as alpha 
melanocortin stimulating hormone (MSH) and neuropeptide Y also heavily innervate the 
PVT while largely avoiding adjacent nuclei (Freedman & Cassell, 1994). The unique 
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innervation patterns within the PVT place this nucleus in an anatomical position to 
integrate the net activity of numerous hypothalamic peptides and brainstem monoamines. 
1.2.2 Efferents of the PVT 
Similar to PVT afferents, the efferent projections of the PVT are quite unique in 
comparison to adjacent thalamic nuclei. Within the entire midline and intralaminar 
thalamic complex, the PVT is the only nucleus to send a dense projection to the nucleus 
accumbens (Berendse & Groenewegen, 1990; Bubser & Deutch, 1998; Hagan et a/., 
1999; Moga et al., 1995; Pinto et al., 2003; Su & Bentivoglio, 1990; VanderWerf et al., 
2002). Other projections from the PVT have been observed to terminate within regions 
of the hypothalamus, hippocampus, amygdala and prefrontal cortex (Moga eta/., 1995; 
Su & Bentivoglio, 1990; VanderWerf eta/., 2002). More specifically, the PVT projects 
to the suprachiasmatic, dorsomedial and lateral hypothalamic nuclei. Projections to the 
amygdala preferentially target the central, basomedial and basolateral nuclei while 
hippocampal projections specifically target the ventral subiculum. Innervation of the 
prefrontal cortex includes the deep layers of the pre limbic and infralimbic cortex while 
fibers coursing towards the striatum terminate with the highest density in the shell of the 
nucleus accumbens (NacSh), a region implicated in motivated behavioral responding. 
Anatomically, it can be proposed that the PVT integrates the net activity of numerous 
arousal-related afferents and relays this information to the NacSh in order to influence 
behavioral patterns. 
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1.2.3 Functional implications of the PVT 
As mentioned in section 1.2.1, the PVT receives visceral sensory information 
from the parabrachial and solitary tract nuclei within the brainstem and projects to the 
infralimbic cortex that is involved in visceral motor functions (Berendse & Groenewegen, 
1991; Chen & Su, 1990; Cornwall & Phillipson, 1988; Krout eta/., 2002; Krout & 
Loewy, 2000a, 2000b; Moga et al., 1995; Ruggiero eta/., 1998). This anatomical 
connectivity has lead researchers to believe that the PVT functions in part to relay 
visceral sensory information to the cortex (Otake & Nakamura, 1998; VanderWerf et 
al., 2002). However, if one considers the overall anatomical properties of the PVT, 
especially the observation that the heaviest efferents of the PVT target the NacSh, it is 
likely that the PVT is involved in behavioral state changes induced by general stress and 
arousal, in which visceral arousal and nociception are included. Studies using c-fos 
mRNA or Fos protein expression to represent neuronal activity show that the PVT is 
consistently active across numerous stress paradigms and during periods of active waking 
and arousal (Bhatnagar & Dallman, 1998; Bubser & Deutch, 1999; Novak & Nunez, 
1998; Novak et al., 2000b; Otake et al., 2002; Peng et al., 1995). In addition, heavy 
innervation of the PVT by feeding-related peptides such as neuropeptide Y and alpha-
MSH (Freedman & Cassell, 1994) suggest that information reflecting the hunger state of 
an animal may also alert the forebrain through a PVT relay. In support of this, food 
deprivation or restriction increases the activity ofPVT neurons (Nakahara eta/., 2004). 
Two novel peptides implicated in arousal and energy homeostasis, termed the orexins and 
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cocaine and amphetamine related transcript (CART), project throughout the brain and 
may contribute to an arousal-induced activation ofPVT neurons. 
1.3 Novel Neuropeptides projecting to the PVT 
1.3.1 The orexins 
The orexin (hypocretin) neuropeptides were discovered in 1998 (de Lecea et a/., 
1998; Sakurai et a/., 1998) and have become a topic of major interest in research 
concerning sleep-wake regulation as well as stress and arousal. The active orexin-A 
(hypocretin-1) and orexin-B (hypocretin-2) peptides are formed from proteolytic 
cleavage of the 130 amino acid precursor prepro-orexin (prepro-hypocretin). The orexins 
bind to two similar G-protein coupled receptors termed orexin receptor 1 (OX1R) and 
orexin receptor 2 (de Lecea eta/., 1998; Sakurai eta/., 1998). Orexin-A and orexin-B are 
co-localized within neurons of the lateral hypothalamus and innervate widespread regions 
of the CNS including the hypothalamus, midline thalamus, cortex, septal area, amygdala, 
and many brainstem areas including monoaminergic and cholinergic cell groups (Cutler 
eta/., 1999; Date eta/., 1999; Nambu eta/., 1999; Peyron eta/., 1998). In line with their 
widespread projections, numerous behavioral and physiological functions have been 
ascribed to orexins including stimulation of wakefulness, feeding and locomotor activity, 
as well as regulation of the autonomic and neuroendocrine systems (Beuckmann & 
Yanagisawa, 2002; de Lecea eta/., 2002; Ferguson & Samson, 2003; Kukkonen eta/., 
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2002; Rodgers eta/., 2002; Siegel, 2004; Taheri eta/., 2002; Willie eta/., 2001). 
Functional differences between the two orexin peptides are unclear and, because they are 
co-localized within the same neurons, the term "orexins" will be used throughout to refer 
to both orexin-A and orexin-B. 
1.3.2 Cocaine and amphetamine related transcript (CART) peptide 
A fragment of the CART peptide was first reported in 1981 (Spiess eta/., 1981) 
and it was discovered years later that the mRNA encoding this peptide fragment was 
increased following administration of either cocaine or amphetamine (Douglass et a/., 
1995). Unlike the orexins, CART peptide is produced in multiple regions throughout the 
brain including the nucleus accumbens, lateral hypothalamus, and the arcuate, solitary 
tract and parabrachial nuclei (Koylu eta/., 1998; Koylu eta/., 1997). CART -containing 
fibers project to widespread areas of the brain including the midline thalamus and a 
majority of other regions innervated by the orexin peptide fibers (see section 1.3.1). 
Since its discovery, CART has been implicated in numerous physiological processes 
including the regulation of food intake, reward and reinforcement, as well as stress and 
arousal (Dominguez eta/., 2004; Hunter eta/., 2004). 
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1.3.3 Functional implications of orexin and CART innervation of the PVT 
Behavioral and in situ hybridization data reveal a role for both the orexin and 
CART peptides in the control of food intake. Central administration of orexins can 
promote food intake (Dube et al., 1999; Ramsey et al., 2005; Sakurai et al., 1998; Sweet 
et al., 1999) and fasting up-regulates orexin mRNA (X. J. Cai et al., 1999; Sakurai et al., 
1998). Conversely, central administration of CART peptide inhibits food intake (Lambert 
et al., 1998; Rohner-Jeanrenaud et al., 2002; Tachibana et al., 2003; Vrang et al., 1999) 
and fasting decreases CART mRNA in the hypothalamus (Kristensen et al., 1998; Li et 
al., 2002; Savontaus et al., 2002). The connection between these peptides and energy 
homoeostasis is consistent with a potential role of the PVT in food intake. Lesions of the 
PVT have been reported to influence feeding behavior (Bhatnagar & Dallman, 1999) and 
to attenuate the increases in both locomotor activity and blood-corticosterone levels 
normally seen during the anticipation of food reward (Nakahara et al., 2004). The orexin 
and CART peptides may contribute to food seeking behaviors in part through a PVT 
relay to the forebrain. 
Another major role for the orexins is in the maintenance of general arousal and 
regulation of the sleep-wake cycle. This is evident in animals with disruptions in aspects 
of the orexin system. For example, mutation ofprepro-orexin or the OX2R gene 
(knockout mice), genetic ablation of orexin neurons (orexin/ataxin-3 transgenic mice) 
and lesions of orexin neurons with the ribosome-inactivating protein saporin toxin in 
adult rats produce animals with disrupted patterns of wakefulness and phenotypes 
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resembling human narcolepsy (Beuckmann eta/., 2004; Chemelli eta/., 1999; 
Gerashchenko eta/., 2001; Hara et a/., 2001; Willie eta/., 2003 ). Consistent with these 
experimental studies, postmortem analyses of brains from dogs or humans with 
narcolepsy show abnormalities in the orexin system (Nishino et a/., 2001; Nishino et a/., 
2000; Thannickal et al., 2000) and suggests that the orexins are necessary for the 
maintenance of wakefulness. This is consistent with studies demonstrating increased 
orexin activity during periods of active waking, high arousal or stress (Espana et a/., 
2003; Kodama eta/., 2005; Yoshida eta/., 2001). It has recently been shown that orexin 
neurons projecting to the PVT are randomly distributed throughout the orexin neuron 
population (Kirouac et a/., 2005) which suggests that the PVT is influenced by the 
activity of the orexin population as a whole and supports the idea that the PVT receives a 
wide array of general arousal information. 
It has been reported that adrenalectomy decreases CART rnRNA and peptide 
levels in hypothalamic regions and that this decrease is alleviated by corticosterone 
administration (Balkan eta/., 2003; Balkan eta/., 2001; Savontaus eta/., 2002; Vrang et 
a/., 2003). These data suggest that arousal and stress can regulate CART synthesis and 
expression. The CART-producing neurons most associated with the stress response, as 
defined by the effect of adrenalectomy on CART mRNA and peptide levels, are found in 
the arcuate nucleus of the hypothalamus (Dominguez eta/., 2004). Interestingly, it has 
recently been shown that the majority of CART innervation ofthe PVT arises from 
neurons in the arcuate nucleus (Kirouac eta/., in press) and suggests that the CART 
projection to the PVT is important in the relay of stress-related information. Overall, the 
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PVT receives a wide range of afferent information: hunger and satiety signals from 
hypothalamic peptides; stress and arousal signals from hypothalamic peptides and 
brainstem monoamines; and visceral sensory and nociceptive signals from various 
brainstem relay nuclei. In light of this, the PVT is likely a region where an overall level 
of general arousal is integrated before being sent to the shell of the nucleus accumbens. 
1.4 The nucleus accumbens shell 
1.4.1 The nucleus accumbens can be divided into core and shell subregions 
The ventral striatum refers to a collection of brain regions in the forebrain which 
receive afferent input from limbic structures such as the medial prefrontal cortex, 
amygdala and hippocampus as well as the PVT of the midline thalamus. The ventral 
striatum has been referred to as the limbic-motor interface based in part on the limbic 
input it receives and its heavy efferent projections to the ventral pallidum, a structure 
closely tied to motor output systems (for review see Mogenson et al., 1980). The most 
prominent region of the ventral striatum is the nucleus accumbens. The nucleus 
accumbens itself can be divided into two subregions that have been termed the "core" and 
"shell" of the nucleus accumbens. Interest in the nucleus accumbens began with early 
reports (Matthysse, 1973; Stevens, 1973) linking the mesolimbic dopamine system, 
which includes a dense dopamine projection from the midline ventral tegmental area 
(VTA) to the nucleus accumbens, to schizophrenic symptoms. Since then the accumbens 
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has been shown to play a key role in substance abuse as well as normal reward-related 
and motivated behaviors (for review see Heimer eta/., 1997; Mogenson eta/., 1980; 
Mogenson and Yang, 1991; Salamone eta/., 2005. Included in the nucleus accumbens is 
a central core which is surrounded medially, ventrally and laterally by the shell region. 
The two divisions are commonly distinguished by immunoreactivity against the calcium 
binding protein calbindin (Zahm, 1992), with immunoreactivity being weak in the shell 
and dense in the core. 
Both regions of the nucleus accumbens are heterogeneous in terms of its afferent 
and chemical composition. Thoroughly summarized by Heimer eta/., (1997), the core 
contains "patches" of tissue where immunoreactivity for the opioid peptide enkephalin is 
dense and dopamine immunoreactivity is weak. The PVT and lateral prefrontal cortex 
project to these areas of the nucleus accumbens core. Conversely, adjacent regions of the 
core exhibiting strong dopamine and weak enkephalin immunoreactivity receive afferents 
from the basolateral amygdala and prelimbic cortex. The shell of the nucleus accumbens 
contains cell-dense regions characterized by low enkephalin and dopamine 
immunoreactivity. Interestingly, areas oflow cell density within the shell receive dense 
dopamine innervation from the VTA and heavy glutamate afferents from the ventral 
subiculum and the PVT. This anatomical heterogeneity may have a functional role, and 
suggests an importance of glutamatergic PVT projections to dopamine-rich areas of the 
NacSh. 
Zahm (2000) has placed the subdivisions of the nucleus accumbens into separate 
"networks" based largely on efferent connectivity. The shell network projects to regions 
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such as the ventromedial ventral pallid urn, preoptic area, lateral hypothalamus, VT A and 
periaqueductal grey, which the author refers to as more "limbic-like" regions associated 
with motivated and goal-directed behaviors. The core network includes the dorsolateral 
ventral pallidurn, entopeduncular nucleus, subthalamic nucleus and substantia nigra, 
which the author refers to as more "basal ganglia-like" regions associated with motor 
output. This is fitting with the nucleus accurnbens as the "limbic-motor interface" 
participating in converting motivation to action, with the shell region concerned more 
with integrating the activity of numerous limbic inputs and the core region concerned 
with sending appropriate signals to motor output systems. 
1.4.2 Dopamine in the NacSh: Gating cortical inputs 
Dopamine release in the NacSh has typically been referred to as the "natural 
reinforcement system" thought to directly mediate the rewarding properties of natural 
reinforcers and drugs of abuse. However, it has become clear that dopamine is involved 
in several aspects of associative learning including aversive learning and therefore cannot 
be responsible for euphoric feelings upon receipt of a natural reward or drug of abuse 
(Blackburn eta!., 1992; Salamone eta!., 2003). It is now widely accepted that dopamine 
release within the NacSh from VTA terminals plays a critical role in the selection and 
facilitation of motivated behavioral responses. As mentioned, numerous glutamate 
afferents overlap within dopamine-rich regions of the NacSh. Specifically, the NacSh 
received goal-oriented cognitive information from the prefrontal cortex, affective 
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information from the amygdala, and contextual information from the hippocampus 
(Grace, 2000). The NacSh is thought to play a role in motivation by acting as a "gate" or 
"filter" having the ability to strengthen or weaken the relative effectiveness each of these 
glutamatergic afferents have on behavioral output (Grace, 2000; Salamone eta/., 2005). 
For example, prefrontal cortex stimulation excites medium spiny output neurons of the 
NacSh but this excitation is attenuated by agonist actions at D2 receptors presumably 
located on corticoaccumbens terminals (Grace, 2000). Furthermore, bath application of 
dopamine attenuates medium spiny neuron excitation evoked by stimulation of the 
amygdala or hippocampus and this attenuation is blocked upon administration of D 1 
receptor antagonists (Charara & Grace, 2003). Thus, dopamine is hypothesized to 
influence motivated or goal directed behaviors through an ability to modulate the effect 
of limbic cortical afferents on the excitability of medium spiny output neurons. 
1.4.3 The regulation of dopamine release in the NacSh 
It has been proposed (Grace, 1991) that glutamate release in the nucleus 
accumbens can act locally on dopamine terminals to modulate the levels of sustained 
tonic ( extrasynaptic) dopamine. This theory states that tonic levels of dopamine set a 
background level of receptor activation that potentiates the effects of phasic dopamine 
release initiated by the burst firing of dopamine neurons. Although the exact role of 
dopamine in the NacSh is complex and yet to be fully understood, the necessity for a 
tight regulation of dopamine is evident in psychiatric disorders such as schizophrenia, 
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attention deficit hyperactivity disorder, and drug abuse, which are all linked to a 
dysregulation of the dopamine system. 
The PVT sends a moderate glutamate projection to the core of the nucleus 
accumbens and a dense glutamate projection to the NacSh (Groenewegen & Berendse, 
1994; Moga eta/., 1995; Pinto eta/., 2003; VanderWerf eta/., 2002). The regions of 
the NacSh innervated by the PVT also exhibit dense immunoreactivity for tyrosine 
hydroxylase, which is likely to represent axon terminals from dopamine neurons in the 
VTA (Pinto eta/., 2003). Although no axo-axonic synapses between glutamate and 
dopamine terminals in the NacSh have been observed to date, numerous studies suggest 
that exogenous glutamate application or endogenous glutamate release can act locally 
within the NacSh to regulate dopamine release (Borland & Michael, 2004; David eta/., 
2005; Kulagina et a/., 2001; Morari et a/., 1998; Whitton, 1997). The PVT, through 
receiving numerous arousal related afferents, may be involved in arousal-induced 
maintenance of dopamine tone within the NacSh. 
1.4.4 Dopamine, stress and food intake 
Various techniques that quantify the concentration of dopamine within a brain 
region over time have all consistently shown that dopamine levels within the NacSh are 
increased following exposure to an acute stressor. By measuring the DOP AC:DA ratio in 
the NacSh, it was demonstrated that acute immobilization stress increases dopamine 
utilization in the shell but not core of the nucleus accumbens (Deutch & Cameron, 1992). 
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Similarly, application of mild footshock to rats increased the dopamine concentration in a 
microdialysis sample taken from the NacSh (Kalivas & Duffy, 1995). Voltarnmetric 
recordings also confirm stress induced dopamine release within the NacSh by showing an 
increase in dopamine oxidation current within the NacSh following tail pinch and 
restraint stress (D'Angio et al., 1987; Doherty & Gratton, 1992). However, repeated 
exposure to unavoidable stressors decreases an animal's behavioral response to 
subsequent acute stressors and this behavioral depression is associated with a decrease in 
dopamine levels within the NacSh (Gambarana et al., 1999) that may be mediated by 
glutamatergic afferents. 
The functional role of dopamine levels in the NacSh is certainly not exclusive to 
stress and arousal, as it is well known that a complex relationship exists between 
dopamine and feeding. Increases in NacSh dopamine levels are associated with both 
food seeking and consummatory behaviors, although various arguments have been made 
supporting a dopaminergic involvement solely in the initiation and maintenance of 
foraging behavior rather than actual consummation of a food. Infusions of dopamine 
directly into the NacSh elicits a feeding response (Swanson et al., 1997) and blockade of 
the D 1 receptor attenuates the increase in feeding induced by an intra-accumbens infusion 
of Jl-opioid receptor agonists (Ragnauth et al., 2000). Additionally, recording dopamine 
levels in the NacSh ofbehaving animals reveals that increased dopamine efflux can be 
seen upon anticipation of a predicted food reward (Roitman et al., 2004) as well as during 
intake of palatable foods (Bassareo & DiChiara, 1999). Interestingly, infusion of 
glutamate agonists and antagonists into the NacSh profoundly influences the feeding 
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response (Maldonado-Irizarry eta/., 1995), and may reflect the effects of a glutamatergic 
presynaptic regulation of striatal dopamine release. 
1.5 Glutamatergic regulation of dopamine 
1.5.1 Glutamate regulation of dopamine: In vitro studies 
The effects of intra-striatal infusion of glutamate agonists and antagonists on 
dopamine levels in the dorsal striatum and nucleus accumbens have produced mixed 
findings. While controversial, there is substantial evidence showing that application of 
glutamate agonists and antagonists in the nucleus accumbens can locally increase and 
decrease dopamine levels, respectively (Borland & Michael, 2004; David eta/., 2005; 
Kulagina eta/., 2001; Morari eta/., 1998; Whitton, 1997). Application ofNMDA in the 
absence of Mg++ was found to increase dopamine release in rat striatal synaptosomes 
and this effect was blocked by either Mg++ or selective NMDA receptor antagonists 
(Johnson & Jeng, 1991; Krebs et al., 1991; Wang, 1991). The same authors further 
demonstrated that application of AMP A and kainate in the presence of Mg++ increases 
dopamine release from rat striatal synaptosomes and is blocked using selective non-
NMDA receptor antagonists. Studies done in rat striatal slices have shown similar results 
in that NMDA applied in Mg++ free conditions dose-dependently increases dopamine 
release from striatal slices (N. S. Cai et al., 1991; Clow & Jhamandas, 1989; Krebs et al., 
1991). Furthermore, application ofL-glutamate in Mg++ free conditions induces an 
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NMDA receptor dependent dopamine efflux in the striatal slice (Bowyer eta/., 1991). 
However, in the presence ofMg++, L-glutamate evokes a response of a smaller 
magnitude, confirming that glutamate actions at non-NMDA receptors also have a 
stimulatory effect on dopamine release. The tendency for local ionotropic glutamate 
agonists to increase striatal dopamine efflux occurs at least in part by an impulse 
independent mechanism as intra-VTA infusions of tetrodotoxin, a substance commonly 
used to prevent action potential firing, fails to block the dopamine response (lravani & 
Kruk, 1996; Krebs eta/., 1991 ). Interestingly, one study has shown that electrically 
evoked dopamine release is facilitated by AMP Alkainate receptor activation in the 
absence ofMg++ and by NMDA receptor activation in Mg++-free conditions (Antonelli 
eta/., 1997). Together these data suggest that ionotropic glutamate receptors have a 
tendency to influence both impulse dependent and impulse independent dopamine 
release. 
1.5.2 Glutamate regulation of dopamine: In vivo studies 
The NacSh receives glutamate afferents from numerous sources including the 
PVT, hippocampus, amygdala, and prefrontal cortex. In vivo data show that electrical 
stimulation of the ventral subiculum of the hippocampus and the basolateral nucleus of 
the amygdala results in impulse independent dopamine efflux in the nucleus accumbens 
(Blaha eta/., 1997; Floresco eta/., 1998; Howland eta/., 2002). The evoked response 
appeared to be mediated by glutamate receptors in the nucleus accumbens because local 
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applications of ionotropic receptor blocking agents attenuated the response whereas 
inactivation of dopamine neurons in the VT A had no effect. This suggests that limbic 
areas sending a glutamate projection to the nucleus accumbens may facilitate impulse 
independent dopamine release and influence tonic dopamine tone in this area of the 
striatum. The data obtained from both in vitro and in vivo studies collectively suggest 
that glutamate actions at ionotropic receptors in the striatum can evoke local impulse 
independent dopamine release. 
1.5 Summary and Hypothesis 
The PVT can be separated from adjacent midline and intralaminar thalamic nuclei 
based on efferent projections to limbic forebrain regions, with an especially dense 
innervation of the NacSh. Furthermore, afferents to the PVT include a wide variety of 
brainstem monoamines and hypothalamic peptides involved in many aspects of stress, 
food intake and general arousal. The experiments in this thesis can be divided into two 
sections with the frrst designed to describe the PVT innervation by the novel orexin and 
CART peptides. Orexin containing cell bodies are found within the lateral hypothalamus 
and perifornical area while neurons immunoreactive for the CART peptide are dispersed 
throughout numerous regions of the hypothalamus and brainstem. Although orexin and 
CART fibers have been previously shown to innervate the PVT, the anatomical data in 
the present thesis provides a full description of orexin and CART immunoreactivity 
throughout the entire midline and intralaminar thalamus as well as the proximity of these 
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fibers to PVT neurons projecting to the NacSh. The PVT projection to the nucleus 
accumbens preferentially targets dopamine-rich striatal tissue while avoiding areas of 
weak dopamine activity. Numerous in vivo and in vitro studies suggest that 
glutamatergic afferents to the striatum, including the NacSh, can regulate local dopamine 
release by acting presynaptically at dopamine terminals. The release of dopamine in the 
NacSh is thought to facilitate behavioral activity and play a role in the expression of 
motivated behaviors. The second section of this thesis is designed to investigate, using in 
vivo voltammetry, any potential modulation ofNacSh dopamine levels by glutamate 
projections from the PVT to the NacSh. I hypothesize that orexin and CART fibers in the 
PVT appose PVT neurons projecting to the NacSh. Furthermore, it is expected that 
excitation ofPVT neurons results in an increase in tonic dopamine levels in the NacSh. 
Such information may introduce the PVT as a critical cell group involved in processing 
an overall level of arousal information and communicating this to the NacSh where it can 
influence tonic dopamine levels and thereby modify the expression of motivated 
behaviors. This proposal is presented as a schematic in Figure 2. 
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Fig. 2. Schematic diagram highlighting anatomical properties ofthe paraventricular 
nucleus of the thalamus (PVT). The PVT likely plays a role in the integration and relay 
of arousal-related information to the nucleus accumbens shell (NacSh) where it may act 
to increase dopamine (DA) release and influence behavioral output. Numerous 
neurotransmitters are released in the PVT including the orexins, CART, norepinephrine, 
serotonin, neuropeptide Y (NPY), alpha-melanocortin stimulating hormone (MSH), and 
corticotrophin releasing factor (CRF). The majority ofPVT innervation originates from 
neurons in various brainstem and hypothalamic nuclei. 
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2.2 Orexin and CART innervation of PVT neurons projecting to the 
NacSh 
2.2.1 Iontophoresis 
Cholera toxin b (CTb; List Biological Laboratory, Campbell, CA) and tluorogold 
(FG; Molecular Probes) were used for the retrograde tract tracing experiments. Subjects 
were anesthetized with equithesin (0.3ml/100g, i.p.), placed in a Kopfstereotaxic frame, 
and a hand drill was used to expose the brain surface above the striatum. The dura was 
removed at the exposed site and a glass pipette (5-10 IJ.m O.D.) filled with retrograde 
tracer solution was positioned 2.0 mm anterior and 1.2 mm lateral to bregma then 
lowered 6.5 mm ventral to the brain's surface. Either 0.5% CTb or 1.0% FG (CTb 
dissolved in physiological saline, FG in O.lM cacodylate buffer) was injected 
iontophoretically by application of a 3 to 5 IJ.A positive current (200 msec pulses at 2 Hz 
for 15 minutes). Pipettes were left in place for an additional2 minutes following 
iontophoresis before removal from the brain. The incision was sutured and subjects were 
allowed 7-14 days to recover. A total of 10 animals (6 FG and 4 CTb) were used in the 
retrograde tracing experiments. 
In an attempt to completely fill the soma and dendrites of PVT neurons, 
neurobiotin was iontophoretically applied to various anteroposterior levels ofthe PVT. 
Pipettes (5-10 J..tm O.D) were filled with 1.5% neurobiotin (Vector Laboratories) in 0.5 M 
NaCI, and a 3-5 J..LA positive current (500 ms pulses at 10Hz for 15 minutes) was applied. 
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Three rats were used and each animal received 2-4 di±Terent injections made at various 
co-ordinates within the dorsal thalamus (0.8 mm lateraL 5.0 mm ventraL and -3.3, -3.0,-
2.7, -2.4 mm posterior: angled 10° in the medial-lateral plane). Animals were given 1-3 
days to recover. 
2.2.2 Tissue preparation 
All animals were perfused through the ascending aorta with 150-200 ml of warm 
heparinized saline followed by 450-500 ml of ice cold 4% paraformaldehyde. Brains 
were removed, post-fixed in the same fixative for 2-4 hours, and then immersed in graded 
sucrose concentrations over two days (1 0 and 20% w/v). Tissue was frozen quickly using 
Fisherbrand Histo-freeze and coronal sections of the brain were cut at 50 !liD on a 
cryostat. 
The nature of the study demanded the use of multiple immunochemical 
combinations to avoid host species overlap of the primary antibodies. All tissue was pre-
incubated in blocking solution (5% normal donkey serum, 0.3% triton X-100, 0.1% 
sodium azide) for one hour at room temperature prior to primary antibody incubation. 
With the exception of the injection sites, all tissue was incubated in the appropriate 
primary antibody cocktail for 24 hours at room temperature and another 24 
hours at 4°C. All fluorophore-conjugated secondary antibody incubations were done for 
2-4 hours at room temperature. All antibodies were diluted in the blocking serum and 
tissue was rinsed thoroughly in PBS between each immunochemical step. Following each 
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immunochemical protocol, sections were rinsed and mounted onto gelatin-coated slides 
where they were left overnight to dry. Slides were then immersed in a series of graded 
alcohol concentrations. cleared in xylene, and coverslipped. 
2.2.3 Immunohistochemistry 
2.2.3.1 Confirmation of injection sites 
Sections of the nucleus accumbens were incubated overnight at room temperature 
in either goat anti-CTb (1 :40,000; List BiologicaL catalogue #703, lot #7032H) or rabbit 
anti-FG (1:40.000; Chemicon, catalogue #AB153.lot #24110032), depending upon 
which tracer injection the animal received. Tissue from animals receiving CTb injections 
was then incubated in a biotinylated donkey anti-goat secondary antibody ( l :500; 
Jackson Immunoresearch) for 2-4 hours at room temperature, then for 2 hours in an 
avidin biotin complex prepared according to kit direction (Elite ABC Kit, Vector 
Laboratories, Burlingame, CA). The histochemical product was visualized by brief 
exposure to 2,4 diaminobenzidine (DAB; DAB Kit, Vector Laboratories), prepared 
according to kit directions. Similar steps were used for those animals receiving rabbit 
anti-FG injections except the secondary antibody used was a biotinylated donkey anti-
rabbit (1 :500; Jackson Immunoresearch). 
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2.2.3.2 Orexin innervation of PVT neurons projecting to the NacSh 
Sections of the PVT were incubated in a cocktail of goat anti-orexin-A ( 1 :2,000; 
Santa Cruz, catalogue #sc-8070, lot #12302), and rabbit anti-FG ( 1: 1 0,000). Tissue was 
then transferred to a biotinylated donkey anti-goat secondary antibody (1 :500), incubated 
in ABC prepared according to kit directions, and reacted in DAB with nickel 
intensification. Sections were transferred to a biotinylated donkey anti-rabbit secondary 
antibody ( 1 :500), and the ABC and DAB steps were completed as before but without 
nickel intensification. 
2.2.3.3 CART innervation of PVT neurons projecting to the NacSh 
Sections of the PVT were incubated in a rabbit anti-CART (l :5,000; Phoenix 
Pharmaceuticals, Inc., Belmont, CA, catalogue #H-003-62, lot #00324) primary antibody. 
Tissue was then transferred to a biotinylated donkey anti-rabbit secondary antibody 
(1 :500), incubated in ABC prepared according to kit directions, and reacted in DAB with 
nickel intensification. Sections were incubated in a rabbit anti-FG (1:10,000) primary 
antibody and transferred to a biotinylated donkey anti-rabbit secondary antibody (1 :500). 
The ABC and DAB steps were completed as before but without nickel intensification. 
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2.2.4 Immunofluorescence 
2.2.4.1 Neuropeptide fiber co-localization with synaptophysin 
To investigate if orexin and CART fibers co-localize with immunoreactivity for 
synaptophysin. a synaptic protein involved in exocytotic release, sections of the PVT 
were incubated in a primary antibody cocktail consisting of mouse anti-synaptophysin 
( l :500; Chemicon) and either goat anti-orexin-A ( 1 :2,000) or rabbit anti-CART 
( 1 :3,000). Tissue was then transferred to a secondary antibody cocktail of Cy5-
conjugated donkey anti-mouse and either Cy3-conjugated donkey anti-goat or Cy5-
conjugated donkey anti-rabbit ( 1 :500; Jackson Immunoresearch). 
2.2.4.2 Orexin innervation of PVT neurons projecting to the NacSh 
Sections of the PVT were incubated in a cocktail of goat anti-orexin-A (1 :2,000) 
and rabbit anti-FG ( 1:1 0,000) primary antibodies. Tissue was then transferred to a 
secondary antibody cocktail of Cy3-conjugated donkey anti-goat and Cy2-conjugated 
donkey anti-rabbit (1 :500). 
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2.2.4.3 CART innervation of PVT neurons projecting to the NacSh 
Sections ofthe PVT were incubated in a cocktail of rabbit anti-CART (1:3,000) 
and goat anti-CTb ( l: l 0,000) primary antibodies. Tissue was then transferred to a 
secondary antibody cocktail of Cy3-conjugated donkey anti-rabbit and Cy2-conjugated 
donkey anti-goat (l :500). 
2.2.4.4 Orexin and CART innervation of PVT neurons projecting to the NacSh 
Sections of the PVT were incubated in a cocktail of rabbit anti-CART ( 1:3.000) 
mouse anti-orexin ( 1: 1 ,000; Alpha Diagnostic International, San Antonio, TX, catalogue 
#OXA 15-M, lot #40514A). and goat anti-CTb ( 1: 1 0,000) primary antibodies. Tissue was 
then transferred to a secondary antibody cocktail of Cy3-conjugated donkey anti-rabbit, 
Cy5-conjugated donkey anti-mouse, and Cy2-conjugated donkey anti-goat (1 :500). 
2.2.4.5 Orexin and CART innervation of PVT cells filled with neurobiotin 
Sections of the PVT from animals receiving the neurobiotin injections were 
incubated in either a goat anti-orexin (1: 1,000) or a rabbit anti-CART (1 :5,000) primary 
antibody. Tissue was then transferred to either Cy2 conjugated donkey anti-goat (for 
orexin fibers) or Cy2 conjugated donkey anti-rabbit (for CART fibers) in a cocktail along 
with TRITC-conjugated Streptavidin (1 :500; Jackson Immunoresearch). 
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2.2.5 Imaging 
The present study used both low and high magnification imaging to examine the 
anatomical relationship between neuropeptide fibers and neurons projecting to the 
NacSh. Low magnitication images were captured at three ditTerent rostrocaudallevels of 
the PVT. The Cy2 and Cy3 fluorophores were captured separately using a conventional 
t1uorescence microscope (BX 51, Olympus) equipped with the appropriate filter cubes 
(U-MNB2 and U-MNG2, Olympus). The separate images ofneuropeptide fibers and 
retrogradely labeled cells were then merged in Adobe Photoshop 5.5. A light microscope 
was also used to capture images of sections stained with DAB as the chromogen. High 
magnification images of orexin and CART fibers innervating retrogradely labeled PVT 
neurons were obtained with a 1 OOx oil immersion lens. Images were captured and 
imported into Photoshop to improve contrast. 
Confocal microscopy (FV300 scan head, BX50WI upright microscope; Olympus) 
was employed to investigate the presence or absence of neuropeptide fiber appositions 
onto retrogradely labeled PVT neurons. The confocal microscope was equipped with blue 
argon ( 488 nm), green helium neon (543 nm), and red helium neon (633 nm) lasers. High 
magnification images were captured with 1 OOx oil-immersion objective lens and a zoom 
setting of 3x. All double labeled sections were scanned at 0.4 !J.m steps except the 
neurobiotin-stained tissue. Corresponding single optical sections for each fluorophore 
were subsequently combined in Adobe Photoshop 5.5 where brightness and contrast were 
adjusted. Each fluorophore was assigned to a particular RGB channel within Photoshop 
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in order to generate those color combinations that resulted in optimal contrast. Sections 
labeled with three t1uorophores were scanned at 1.0 Jlm steps and were visualized as a 
small stack of optical sections. 
Sections of the PVT treated with neurobiotin were imaged with the confocal 
microscope setup as described above. The neurobiotin signal and either the orexin or 
CART signal were imaged through 3- 5 optical sections of 1 Jlm each. For each pseudo-
section, the neurobiotin-filled cell and any neuropeptide tiber contacts were isolated from 
the background in Adobe Photoshop. These cut images were then stacked together to give 
the appearance of an isolated cell receiving multiple tiber contacts. The background was 
removed to clearly show contacts on the soma and dendrites of a single PVT neuron 
without interference from the dense background staining. 
2.3 Effect of PVT stimulation on dopamine levels in the NacSh 
2.3.1 Surgery 
Rats were anesthetized with urethane (1.6 mglkg, i.p.) and placed in a Kopf 
stereotaxic frame. The femoral vein was cannulated in a few animals for apomorphine 
administration. Body temperature was maintained at 3 7 °C using a Deltaphase isothermal 
heating pad (Braintree Scientific, Inc.). A hand drill was used to make holes overlying the 
striatum and diencephalon. Stimulating and recording electrodes (see below) were 
lowered into the thalamus and NacSh, respectively. The stimulating electrode was always 
33 
inserted on a 10 degree angle from the midline to avoid puncturing the mid-sagittal sinus. 
An Ag/ AgCl reference electrode was inserted in the left hemisphere of all animals 
through a small hole drilled 7-8 mm posterior to bregma. All stereotaxic coordinates were 
derived from a rat brain atlas (Paxinos & Watson, 2005) and are described in more detail 
below. 
2.3.2 Electrochemical detection 
The Nafion-coated carbon fiber electrodes (30 J.Lm tip diameter x 150 J.Lm length, 
Quanteon, Nicholasville, KY) used in the present study to monitor dopamine release have 
been shown to provide excellent selectivity for dopamine over ascorbic acid and 
dihydroxyphenylacetic acid (Gerhardt & Hoffman, 2001). A new electrode was used for 
each animal and all electrodes were calibrated in vitro prior to experimentation. An 
electrode was used only if it responded in a highly linear fashion (~ > 0.98) to 2.5 J.LM 
additions of dopamine up to 10 J.LM while demonstrating at least a 100:1 selectivity for 
dopamine over ascorbic acid and DO PAC in vitro. The limit of detection for dopamine 
was defined as the concentration required to produce a response with a signal-to-noise 
ratio of 3:1. Amperometric recording of dopamine was performed by applying a 700 m V 
potential (vs. Ag/ AgCl) to a carbon fiber electrode which was connected to a head stage 
pre-amplifier and sent to a computer-controlled instrument (FAST -16, Quanteon, L.L.C., 
Nicholasville, KY). Recordings were acquired at a sampling rate of 1 Hz. High speed 
chronoamperometric recordings were carried out by applying square wave pulses (0 to 
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550 mV vs. Ag/AgCl) to the carbon fiber electrode for 100 ms at 5Hz. Pre-calibration 
revealed the detection limits for amperometry to fall between 5 and 15 nM and frequently 
exceed 50 nM for high-speed chronoamperometry. Since constant potential amperometry 
was found to yield the best signal-to-noise ratio, it was used for the majority of 
recordings (addressed further in results). Chemical specificity of the signal was also 
confirmed to be dopamine by examining the reduction/oxidation (redfox) ratio from 
recordings done using high-speed chronoamperometry. 
2.3.3 Effect of thalamic stimulation on oxidation current in the NacSh. 
A concentric bipolar stimulating electrode (SNE-1 00, Rhodes Medical 
Instruments, Summerland, CA) was lowered dorsal to the thalamus (approximately 4.5 
mm ventral to the brain surface). Monophasic current pulses were applied (1.0 ms pulses 
at 40Hz for 5 s) and dopamine release was monitored in the NacSh. Pilot experiments 
indicated these stimulation parameters to be optimal to evoke an electrochemical signal in 
the NacSh using amperometry and chronoamperometry. The stimulating electrode was 
gradually lowered through the thalamus in 200 Jlm increments, with stimulation 
occurring at each site. Electrochemical events were saved and the corresponding thalamic 
stimulation coordinate was carefully noted for future histological identification. For each 
animal, 2-5 tracts were made through various anteroposterior and mediolateral regions of 
the thalamus. Anteroposterior coordinates ranged from 1. 0 mm to 3.2 mm posterior to 
bregma and mediolateral coordinates ranged from 0.0 to 2.0 mm to the left and 0.0 to 1.0 
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mm to the right of the mid-sagittal sinus. Each experiment was terminated by passing a 
positive direct current (800 !J.A, 10- 15 s) through the carbon fiber electrode. These 
current parameters produced a small lesion at the electrode tip, facilitating histological 
verification of the recording site. 
Animals were perfused transcardially using 150 ml ofheparinized saline followed 
by 500 ml of 10% formalin. Brains were removed and post-fixed in 10% formalin 
overnight. Sections were cut at 100 11m on a vibratome, mounted on gelatin-coated slides, 
and stained using a standard Nissl stain. Sections were then examined with a microscope 
(BX 51, Olympus) to determine the placement of the carbon-fiber electrode within the 
NacSh as well as the ventral-most site of each tract made by the stimulating electrode in 
the thalamus. Each stimulation site was identified by estimating the location of each 200 
11m increment dorsal to the damage made by the electrode tip. A stimulation site in the 
thalamus was considered to evoke a response in the NacSh if the recorded current 
increase occurred following the onset of stimulation and peaked above the limit of 
detection. Responses were converted to represent a change in dopamine concentration 
based on pre-calibration data for each microelectrode. 
2.3.4 Effect ofnomifensine on the PVT-evoked oxidation current in the NacSh. 
Five animals were used to determine ifthe properties of the observed 
electrochemical signal were sensitive to the dopamine uptake inhibitor nomifensine. The 
stimulating electrode was placed in the posterior PVT (3 .2 mm posterior to bregma and 
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immediately to the left hemisphere avoiding the mid-sagittal sinus) while the recording 
electrode was placed in the medial shell ofthe nucleus accumbens (1.1 mm anterior and 
1.1 mm lateral to bregma and 7.0 mm below the brain surface). If necessary, the 
electrodes were adjusted in the dorsal-ventral direction to find a response exceeding the 
detection limit. Typically, a response was found within one or two adjustments of the 
stimulating electrode. Subjects were injected with the dopamine uptake inhibitor 
nomifensine (20 mglkg, i.p.). The PVT was stimulated once every 5 minutes thereafter 
and electrochemical activity in the NacSh was monitored as before. Animals were 
perfused at the end of the experiment and tissue was processed as in section 2.3.3. 
2.3.5 Effect of intra-VTA lidocaine on PVT -evoked oxidation current in the NacSh 
Four animals were used to investigate whether the observed electrochemical event 
evoked by PVT stimulation is dependent on the firing of dopamine neurons in the VT A. 
The coordinates detailed in section 2.3.4 were used to stimulate the PVT and record 
events in the NacSh. A pipette (50- 75 1..1.m O.D.) filled with 4% lidocaine was centered 
above the VTA 5.0 mm posterior and 1.1 mm lateral to bregma. The pipette was lowered 
approximately 1.0 mm into the cortex while a PVT-evoked response was found to assure 
that any diffusion from the pipette had no effect on the initial electrochemical recordings. 
When a stimulation site was found, the pipette was lowered 8.5- 9.0 mm below the brain 
surface and another 2 - 3 PVT -evoked responses were recorded before lidocaine 
infusion. A total of 2 1..1.1 of lidocaine was infused over a three minute period into the VT A 
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using a pressure injection device (Harvard Apparatus, Holliston, MAS). The volume 
ejected was determined by carefully observing the position of the meniscus in the 
micropipette. The PVT was stimulated every 5 minutes following lidocaine 
administration and electrochemical measurements were recorded in the NacSh. Animals 
were perfused and tissue was processed for histological verification. 
2.3.6 Effect of kynurenic acid on PVT -evoked oxidation current in the NacSh 
Six animals were used to investigate the contribution of local glutamate receptors 
to PVT -evoked electrochemical currents recorded in the NacSh. Kynurenic acid was used 
as a broad spectrum glutamate receptor antagonist at NMDA, AMP A, and kainate 
receptors (Stone, 1993). A recording electrode and a glass pipette filled with kynurenic 
acid (O.D. 50-75 J.Lm) were both lowered over bregma, with the pipette angled at 10 
degrees from the midline. The pipette was inserted into the brain 1.2 mm anterior, 2.4 
mm lateral to bregma, and 7.1 mm ventral to the brain surface. The electrode was then 
lowered 1.2 mm anterior, 1.1 mm lateral to bregma, and 7.0 mm ventral to the brain's 
surface. Histological analysis indicated that there was a range of 200 - 400 J.LID between 
the tip of the pipette and recording electrode. A stimulating electrode was then placed in 
the PVT and an electrochemical response was evoked in the NacSh as described in 
section 2.3.4. A PVT-evoked event was recorded every 5 minutes for 15 minutes and 
followed by an infusion of 50 mM kynurenic acid. The PVT was stimulated every 5 
minutes following kynurenic acid application and electrochemical activity was recorded 
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in the NacSh as before. Control experiments were done in the same animals as the 
kynurenic acid experiments with three animals receiving saline before kynurenic acid and 
three animals receiving kynurenic acid before saline. Both treatments were infused at a 
volume of 500 nl over 3 minutes. At least two hours were allotted between injections so 
that any effect observed by the initial treatment had time to recover. 
Since kynurenic acid did not fully block the response, further experiments 
examining the role of dopamine cell firing were carried out. The effects of apomorphine, 
a mixed dopamine agonist known to have inhibitory effects by acting on autoreceptors 
located on dopamine neurons (Grace & Bunney, 1983), on PVT -evoked responses were 
examined in four of the six animals used in the kynurenic acid experiments. The effects 
of apomorphine could be reliably tested in the same rats due to the full recovery of PVT-
evoked electrochemical events within an hour following kynurenic acid application. 
Apomorphine (0.15 mg/kg; i.v.) was delivered at a rate of 1 mVminute. PVT-evoked 
events were recorded before apomorphine administration and every 5 minutes thereafter. 
Animals were perfused at the end of the experiment and tissue was processed as 
described in section 2.3.3. 
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2.3. 7 Anterograde tracing 
Six rats were anesthetized with equithesin (0.3 ml/lOOg, i.p.) and placed in a Kopf 
stereotaxic frame. Iontophoretic injections of2% biotinylated dextran amine (BDA; 
Sigma) dissolved in PBS were performed by applying a 5-6 !lA positive current (7s 
on/off for 30 minutes) through a chlorinated silver wire placed in a glass pipette (7-10 1J.ffi 
·tip diameter). The coordinates used for injecting BDA into various anteroposterior 
regions of the PVT were as follows: 1.0 or 3.0 mm posterior and 0.8 mm lateral to 
bregma (angled at 10° from the midline), and 5.0 mm ventral to the dura. The scalp 
incision was sutured and rats were returned to their home cages for recovery. Following 
a 10-14 day postoperative survival, rats were deeply anesthetized with equithesin (0.4 
ml/lOOg, i.p.) and perfused with 150 ml heparinized saline followed by 450-500 ml ice-
cold 4% paraformaldehyde. The brains were removed, post-fixed for 2-4 hours, and 
cryoprotected in graded sucrose concentrations (10% and 20% w/v). Brains were then 
frozen using Fisherbrand Histo-freeze and sections from the nucleus accumbens and 
thalamus were taken at 50 IJ.m and collected in PBS. Brain sections were incubated in 
ABC overnight at 4 °C. After a few rinses, the tissue was reacted for 5-10 minutes with 
diaminobenzidine (DAB) with nickel intensification to produce black BDA labeling. 
Sections were then stained for tyrosine hydroxylase (TH) by incubating in mouse 
monoclonal anti-TH (Sigma; 1:1 00,000) overnight at 4°C followed by an ABC/DAB 
reaction without nickel intensification as described above. Sections were examined using 
a standard light microscope (Olympus BX51) equipped with a digital camera (SPOT RT 
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Slicer, Diagnostic Instruments Inc, Sterling Heights, MI) and images were captured and 
transferred to Adobe Photoshop 5.5 to optimize light and contrast levels. 
2.3.8 Chemicals and Drugs 
Nomifensine, lidocaine, and kynurenic acid were all purchased from Sigma (St. 
Louis, MO, USA). Chemicals were dissolved in 0.9% saline with the exception of the 
kynurenic acid which was dissolved ftrst in a drop of sodium hydroxide and then diluted 
with saline. Hydrochloric acid was used to adjust the pH of the kynurenic acid solution to 
7.4. 
2.3.9 Data Analysis 
All voltammetric signals were analyzed by converting each recorded current to a 
concentration based on pre-calibration responses to known concentrations of dopamine. 
The events observed in the present studies were brief, usually returning to baseline within 
20 seconds. To account for baseline drift, inherent in voltammetric recording methods, a 
new baseline was established for each response by averaging 4 data points prior to PVT 
stimulation. Oxidation current changes caused by PVT stimulation were calculated as a 
change from baseline which was then converted to a concentration value. A paired t-test 
was used to compare the average peak and clearance rate of dopamine signals before and 
after both nomifensine and lidocaine infusion. A single factor analysis of variance was 
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used to examine the effect of kynurenic acid and apomorphine on dopamine peak values 
at various time points following drug administration. Post-hoc comparisons were made 
using Tukey's test. 
42 
Chapter 3 
Results 
3.1 Results Summary: Anatomy 
The anatomical findings of the present thesis demonstrate that the PVT contains 
the highest density of orexin and CART immunopositive fibers when compared to 
adjacent thalamic nuclei. Both fiber types typically co-expressed immunoreactivity for 
the synaptic marker synaptophysin suggesting that orexin and CART are released from 
vesicles within the PVT. The PVT was the only thalamic region to receive a dense 
innervation from both the orexin and CART peptides while exhibiting dense retrograde 
labeling from the NacSh. High magnification confocal imaging revealed orexin and 
CART fiber varicosities within the PVT made frequent putative contacts with the soma 
and proximal dendrites ofPVT neurons projecting to the NacSh. 
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3.2 Orexin and CART innervation of PVT neurons projecting to the 
NacSh 
3.2.1 Orexin fiber innervation of the midline and intralaminar thalamus 
A high density of orexin fiber immunoreactivity was observed throughout the 
anteroposterior extent of the PVT (Fig. 3) with the heaviest innervation occurring in more 
posterior regions (Fig. 3E). The shape of the PVT changes in posterior regions to occupy 
a greater proportion of thalamic tissue immediately lateral to the midline. The 
observation that orexin fiber immunoreactivity patterns follow this change in shape 
suggests that antibodies against the orexin-A peptide can be used to distinguish the PVT 
from adjacent nuclei. Orexin fiber immunoreactivity was found to be weak in the 
paratenial nucleus which is located lateral to the PVT in anterior sections (Fig. 3 A, B). 
A moderate density of orexin fibers were found in the intermediodorsal nucleus which is 
located ventral to the PVT in posterior sections (Fig. 3D, E). There was a considerable 
orexin fiber presence within the centromedial nucleus, with heavier staining observed in 
more posterior sections (Fig. 3 C-E). A barely detectable level of orexin fiber 
immunoreactivity was found in the mediodorsal and paracentral nuclei (Fig. 3 C-E). 
Examination of orexin fibers in the PVT at high magnification (Fig. 3 F) revealed 
unevenly spaced fiber swellings of various sizes which are characteristic of en passant 
enlargements. Thick branched and un-branched fibers with a beaded appearance ran in 
all directions with fibers often terminating in a cluster of beads. 
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Fig. 3. The photomicrographs in panels A toE show the distribution of orexin-like 
immunoreactive fibers in the para ventricular nucleus of the thalamus (PVT). The shape 
of the PVT varies slightly throughout its anteroposterior extent but is well defined at each 
level by heavy orexin immunoreactivity. In general, the PVT is easily distinguished from 
adjacent thalamic nuclei by dense orexin innervation. Numbers indicate approximate 
distance from bregma. Panel F shows fibers and swellings in the PVT immunostained for 
orexin and captured under lOOX oil immersion lens. AN, anterior nucleus of the 
thalamus; CM, centromedial nucleus of the thalamus; Hb, habenula; IMD, 
intermediodorsal nucleus of the thalamus; MD, mediodorsal nucleus of the thalamus; PC, 
paracentral nucleus ofthe thalamus; PT, paratenial nucleus ofthe thalamus; PVA, 
anterior para ventricular nucleus of the thalamus; PVP, posterior paraventricular nucleus 
of the thalamus; PVT, paraventricular nucleus of the thalamus; sm, stria medullaris 
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3.2.2 CART fiber innervation of the midline and intralaminar thalamus 
A high density of CART fiber immunoreactivity was observed throughout the 
anteroposterior extent of the PVT (Fig. 4) with the heaviest innervation seeming to occur, 
as seen with orexin fibers, in more posterior regions (Fig. 4 D, E). Furthermore, the 
rostrocaudal shape ofthe PVT (described in 3.2.1) is closely followed by CART fiber 
immunoreactivity suggesting that antibodies against CART can be used to distinguish the 
PVT from adjacent nuclei, as was the case with orexin. CART fiber immunoreactivity 
was found to be weak in the paratenial, centromedial and intennediodorsal nuclei (Fig. 4 
A-E), and slightly above background levels in the mediodorsal nucleus. The anterior 
thalamic nucleus contained moderate CART fiber immunoreactivity throughout (Fig. 4 
B-D), as previously described (Koylu eta/., 1998). Examination of CART fibers in the 
PVT at high magnification (Fig. 4F) revealed a high density of en passant enlargements 
suggestive of transmitter release. As with orexin, thick branched and un-branched CART 
fibers with a beaded appearance ran in all directions with fibers often terminating in a 
cluster of beads. 
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Fig. 4. The photomicrographs in panels A toE show the distribution of CART-like 
immunoreactive fibers in the paraventricular nucleus of the thalamus (PVT). The shape 
of the PVT varies slightly throughout its anteroposterior extent but is well defined at each 
level by heavy CART immunoreactivity. In general, the PVT is easily distinguished 
from adjacent thalamic nuclei by dense CART innervation. Numbers indicate 
approximate distance from bregma. Panel F shows fibers and swellings in the PVT 
immunostained for CART and captured under IOOX oil immersion lens. AN, anterior 
nucleus of the thalamus; CM, centromedial nucleus of the thalamus; Hb, habenula; IMD, 
intermediodorsal nucleus of the thalamus; MD, mediodorsal nucleus of the thalamus; PC, 
paracentral nucleus ofthe thalamus; PT, paratenial nucleus of the thalamus; PVA, 
anterior paraventricular nucleus of the thalamus; PVP, posterior paraventricular nucleus 
of the thalamus; PVT, paraventricular nucleus of the thalamus; sm, stria medullaris 
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3.2.3 Neuropeptide fiber co-localization with synaptophysin 
Immunofluorescent experiments were carried out to investigate whether orexin 
and CART immunoreactive fibers co-localize with synaptophysin, a synaptic vesicle 
protein involved in vesicular release from terminals. Both fiber types were found to co-
express synaptophysin immunoreactivity on axonal terminals and enlargements 
throughout the anteroposterior and mediolateral extent of the PVT (Fig. 5). Examination 
of 0.4 !J.m optical sections of sequential scans of the PVT revealed considerable 
synaptophysin presence within enlargements of labeled fibers. The overlap between 
orexin and synaptophysin and CART and synaptophysin was consistently found on the 
enlargements and not on segments of fibers between enlargements. 
3.2.4 Location of retrograde tracer deposits in the NacSh 
Retrograde tract tracing experiments were done to label thalamic neurons 
projecting to the NacSh. Only those animals with tracer injection largely restricted to the 
shell region of the nucleus accumbens were used in the present experiments. As shown 
in Figure 6, the dense cores of the injections were found in the anterior, middle, and 
posterior aspects of the medial NacSh. These locations throughout the NacSh cover the 
extent of the nucleus accumbens which have been previously described to receive 
afferents from the PVT (Moga eta!., 1995). 
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Fig. 5. Representative case demonstrating that orexin (A-C) and CART (D-F) fiber 
varicosities typically co-express immunoreactivity for synaptophysin (arrows, C, F), a 
protein that has been used as a reliable marker of synaptic vesicle release. Typically, 
double labeling was confined to the swellings of immuno-labeled fibers rather than the 
intervaricose segments. Each image represents a single optical section of 0.4 J..Lm captured 
using confocal microscopy. Syp, synaptophysin. 
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Fig. 6. Approximate location of 6 fluorogold (A) and 4 cholera toxin b injections (B). 
The rostrocaudallevels shown are the ones at which the tracer immunoreactivity was the 
strongest. The majority of injections from both tracers were restricted to the dorsomedial 
nucleus accumbens shell (NacSh). Numbers represent approximate distance anterior to 
bregma. ac, anterior commissure; NacC, nucleus accumbens core. 
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3.2.5 Overlap between orexin and CART immunoreactivity and thalamic neurons 
projecting to the NacSh 
Immunof1uorescent labeling of orexin and CART fibers in the midline and 
intralaminar thalamus provide the same specificity as observed using DAB as the 
chromogen (see sections 3.2.1 and 3.2.2). Dense immunoreactivity for orexin (Fig. 7 O-
F) and CART (Fig. 7 G-I) was observed to concentrate medially beneath the third 
ventricle in anterior sections (Fig. 7 D, G) and extend laterally in posterior sections (Fig. 
7 F. I). The locations of neurons retrogradely labeled from the NacSh followed this 
pattern of tiber immunoreactivity, demonstrating that the majority of thalamic neurons 
projecting to the NacSh are found within the boundaries of the PVT. Dense tiber staining 
was not common to the entire midline and intralaminar thalamus as regions adjacent to 
the PVT exhibited little or no staining at all. The paratenial nucleus was the only other 
thalamic nucleus to exhibit CTb-positive neurons but this nucleus was largely devoid of 
orexin and CART fiber staining (Fig. 7 D, G). 
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Fig. 7. Fluorescent images showing the distribution of retrogradely labeled cells in the 
paraventricular nucleus of the thalamus (PVT) following cholera toxin b (CTb) injection 
in the nucleus accumbens shell (A-C). Patterns of retrograde labeling largely overlapped 
immunofluorescence for orexin (OX, D-F) and CART fibers (G-1). This overlap was 
evident throughout the anterior (D, G), middle (E, H), and posterior (F, I) regions of the 
PVT. Numbers indicate approximate distance from bregma. 3V, 3rd ventricle; MD, 
mediodorsal nucleus; Pt; paratenial nucleus. 
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3.2.6 Orexin and CART fiber innervation of PVT neurons projecting to the NacSh 
Orexin and CART fiber innervation of PVT cells retrogradely labeled from the 
nucleus accumbens were examined with high magnification light and confocal 
microscopy. Examination of sections stained with DAB revealed putative fiber contacts 
onto FG-positive cells (Fig. 8). These presumed contacts were easily identifiable in 
sections stained for orexin and FG (Fig. 8 A-C) as well as those stained for CART and 
FG (Fig. 8 0-F). Fibers were commonly seen to wrap around a labeled soma, sometimes 
appearing to terminate at a point near or on the cell body. Although no quantitative 
analysis was performed. it appeared that orexin and CART fibers formed a similar 
number of contacts onto labeled PVT neurons. 
High magnification confocal images were collected at 0.4 ~-tm steps to provide 
further evidence of appositional contacts. Figure 9 shows that both orexin (Fig. 9 A-C) 
and CART (Fig. 9 D-F) tiber appositions onto PVT neurons projecting to the NacSh are 
evident within single optical sections. Although the FG tracer generally labeled a greater 
proportion of individual PVT neurons when compared to CTb, neither FG nor CTb 
generated complete staining of both the soma and dendrites. Typically no more than half 
the cell body would show signs of immunofluorescence and dendritic staining was 
observed only in very rare cases. At best, a fiber could be seen apposing a dendrite 
approximately 10 ~-tm away from the cell body (Fig.9 A, D), providing at least some 
evidence for the existence of axodendritic appositions as well as the more commonly 
observed axosomatic appositions. 
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Fig. 8. High magnification light microscope images showing putative fiber contacts onto 
neurons (brown) in the para ventricular nucleus of the thalamus (PVT) retrogradely 
labeled with fluorogold (FG) from the shell of the nucleus accumbens. Orexin (OX, A-C) 
and CART fibers (D-F) appear black from a nickel-intensified diaminobenzidine 
reaction. Arrows show fiber enlargements apposing labeled PVT neurons. 
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Fig. 9. High magnification confocal images showing putative fiber contacts onto cells of 
the paraventricular nucleus of the thalamus (PVT) retrogradely labeled from the shell of 
the nucleus accumbens (red). Images shown are single 0.4 1-1m optical sections removed 
from a stack. Labeled PVT cells were commonly apposed by orexin (OX, green; A-C) 
and CART fibers (green, D-F). In a few cases where the retrograde tracer filled a 
proximal dendrite of a PVT cell, presumed axodendritic contacts were evident 
(arrowheads, A, D). Arrows show representative fiber contacts onto labeled PVT 
neurons. 
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Experiments were also performed to assess whether the same PVT neuron 
retrogradely labeled from the NacSh is apposed by both orexin and CART tiber types. 
Retrogradely labeled cells were scanned throughout the z-axis at 1.0 ~-tm. and the same 
levels were sequentially scanned once again to capture both orexin and CART 
immunot1uorescence. Due to the unlikely chance that both fiber types may appose a 
single CTb labeled cell within the same optical section, a series of three to five optical 
sections ( 1.0 ~-tm steps) of the CTb signal alone was captured and stacked. The optical 
sections at which the orexin and CART contacts occurred were then superimposed on the 
CTb stack. Orexin and CART fibers were commonly seen apposing the same PVT 
neuron (Fig I 0). 
The full shape of a PVT neuron was much more readily identifiable following 
injection of neurobiotin into the PVT. Examination of neurobiotin-tilled cells at the light 
microscopic level revealed that PVT neurons have short proximal dendrites that quickly 
taper to fine distal dendrites. We could capture confocal images of the neurobiotin-tilled 
soma and proximal dendrites, but were unable to clearly visualize the distal dendrites of 
PVT neurons because of their very fine taper. By combining neurobiotin with orexin or 
CART immunofluorescence, numerous fiber contacts were seen on both the soma and 
proximal dendrites of PVT neurons. In cases of more complete filling of PVT neurons, 
evidence for both axosomatic and axodendritic appositions was seen in all PVT cells 
scanned and was noted for both orexin and CART fiber types (Fig. 11). 
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Fig. 10. High magnification confocal images demonstrating both orexin (OX, green) and 
CART fiber (blue) contacts onto a common PVT neuron (red) retrogradely labeled with 
cholera toxin b (CTb) from the nucleus accumbens. Each image represents a stack of3-
5 optical sections taken through the z-axis at 1.0 J.lm steps. Arrows show representative 
fiber contacts onto labeled PVT neurons. 
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Fig. 11. High magnification confocal images demonstrating the presence of orexin 
(green, A-C) and CART (green, D-F) fiber contacts onto both the soma and dendrites of 
filled neurons within the paraventricular nucleus of the thalamus (PVT). Neurobiotin 
(red) was iontophoretically applied into the PVT. Each image represents a stack of3- 5 
optical sections taken though the z-axis at 1.0 !J.m steps. 
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3.3 Results Summary: Voltammetry 
The voltammetry data demonstrate that electrical stimulation of the PVT resulted 
in a transient increase in an oxidation current within the NacSh which was characteristic 
of dopamine release. The PVT -evoked increases in NacSh oxidation current were not 
dependent on the firing of midbrain dopamine neurons as intra-VTA lidocaine and i.p. 
apomorphine administration had no effect on PVT -evoked responses. Furthermore, 
infusion of the ionotropic glutamate receptor antagonist kynurenic acid significantly 
attenuated the peak of PVT -evoked responses, suggesting that glutamate release from 
PVT terminals acts presynaptically to regulate tonic dopamine release. 
3.4 Effect of PVT stimulation on dopamine levels in the NacSh 
3.4.1 Selectivity of electrochemically-de'tected events 
From the observation that the PVT is heavily innervated by numerous arousal 
related peptides including the orexins and CART, it was of interest to determine if the 
output of the PVT plays any role in modulating dopamine release within the NacSh. 
Initial voltammetry experiments using nafion-coated carbon fiber electrodes revealed an 
increase in oxidation current in the NacSh following PVT stimulation. Attempts were 
made to successfully record PVT -evoked responses using high-speed 
chronoamperometry. In many instances, a change in oxidation current clearly observed 
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using constant potential amperometry (Fig. 12A) was typically lower than the limit of 
detection for high-speed chronoamperometry (Fig 12B). Variations that were seen in the 
observed response size allowed chronoamperometric detection for some of the larger 
events. When a response was found using amperometry (Fig. 12C) that was above the 
limit of detection for chronoamperometry, the recording mode was switched to 
chronoamperometry and a red/ox ratio reflecting that of dopamine (0.7- 0.8) was 
observed (Fig. 12D). However, the majority of events fell below the chronoamperometric 
detection limit and were much better recognized using amperometry (Fig. 12A) compared 
to chronoamperometry (Fig. 12B). Therefore, constant potential amperometry was used 
for the remainder of the experiments. 
3.4.2 Effect of thalamic stimulation on oxidation current in the NacSh 
Stimulation of specific regions of the midline and intralaminar thalamus generated 
a transient increase in oxidation currents within the NacSh. By lowering the stimulating 
electrode through multiple tracks at various anteroposterior and mediolaterallevels of the 
thalamus, it was determined that stimulation of the PVT consistently evoked an increase 
in oxidation current in the NacSh whereas stimulation of adjacent nuclei did not (Fig. 13). 
Stimulation of the mediodorsal, lateral habenular and centromedial nuclei, as well as the 
stria medullarius and fasciculus retroflexus fiber tracts, resulted in no oxidation current 
change in the NacSh. Certain placements in the lateral aspect of the mediodorsal nucleus 
or the dorsal aspect of the intermediodorsal nuclei were found to evoke a NacSh response 
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Fig. 12. A transient electrochemical signal is observed in the NacSh following 
stimulation of the thalamus. Pilot data revealed certain placements to generate low 
magnitude responses (20-30 nM) which were more easily detected using constant 
potential amperometry (A) compared to high-speed chronoamperometry (B). A few cases 
were found in which the oxidation current change detected by amperometry (C) was large 
enough to be detected by chronoamperometry (solid line, D). For these cases, a rise in 
oxidation current was accompanied by a rise in reduction current (dotted line, D) which 
reflected a redox ratio typical of dopamine (0.7-0.8). Note the difference between 
electrochemical signals using amperometry (A, C) as compared to high-speed 
chronoamperometry (B, D). All current responses are translated to a concentration value 
based on pre-calibration data. 
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Fig. 13. Stimulation of the dorsal midline thalamus increased electrochemically detected 
dopamine in the nucleus accumbens shell (NacSh). Various thalamic nuclei (A) were 
stimulated while electrochemical current was monitored in the NacSh. Thalamic 
stimulation sites resulting in a transient NacSh dopamine oxidation current rising above a 
3:1 signal-to-noise ratio concentrate within the paraventricular nucleus of the thalamus 
(PVT, filled circles, B). Stimulation of the adjacent mediodorsal (MD), centromedial 
(CM), and lateral habenular nuclei (LHb) did not raise the dopamine oxidation current in 
the NacSh (hollow circles). Carbon fiber electrode placements within the NacSh are 
shown for each of9 subjects (C). Numbers indicate approximate distance anterior(+) 
and posterior (-) to bregma. 
72 
A 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
', / 
' 
' 
' 
' 
' 
' 
/ 
-1.40 mm 
~ /1 ,PVT, ,, 
I I \ I l \ 
I : 'y·-y : l ~L' } I MD I t 
\ ''-'. IM~ 1 \ 4../ 
1
,' 
'< ........ ..._ ... / \ .. ""' ......... ~- ... ~~ :/ 
',,/ CM \ .,"-' 
_________ J' ... 
-3.60 mm 
B 
' 
' 
' 
' 
' 
' ' 
' 
' 
' 
' 
' 
', 
, ______ _ 
0 ' 
' 
--
' 
' 
' 
c 
,/ 
' 
LS i / / ... , 
' ' I I ',, I. I ', ~~ • \ Nacc~----,,, 
: : \ aca \ 
II ' I '~ NacSh ',, ~ 
'\ ........... ____ ... "' 
CPu 
',, 
'>:::.::-:.:::iii:\---
in a few cases, but these placements fell in a region directly adjacent to the PVT. 
The lateral-most portion of the mediodorsal nucleus was stimulated in a number of cases 
and each time had no effect on oxidation current in the NacSh. Each time a response was 
found, the current intensity was lowered from 400 J..I.A to determine the lowest stimulation 
current necessary to elicit an increase in oxidation current within the NacSh. When the 
stimulating electrode was directly in the PVT responses could be observed using a 
current intensity of 150J.!A. No response was ever seen using currents less than 150 J..I.A. 
3.4.3 Effect of nomifensine on the PVT -evoked oxidation current in the NacSh 
The dopamine uptake inhibitor nomifensine (20 mglkg; i.p.) was used to confirm 
the dopaminergic identity of the detected electrochemical event observed in the NacSh 
following PVT stimulation. By inhibiting dopamine uptake, any PVT -evoked release of 
dopamine would remain in the extracellular space for a longer period of time and should 
be reflected in the resulting oxidation current. A PVT -evoked event was compared 
before and 30 minutes after nomifensine injection. Nomifensine increased the peak (Fig. 
14A; p < 0.05) as well as the time taken to decay to 80% of the peak value (Fig. 14B; p < 
0.001) of the oxidation current response. This change was noted as soon as 10 minutes 
following nomifensine administration and was maintained for at least one hour. Examples 
of the effect of nomifensine on the response signal are shown from two representative 
cases (Fig. 14 C, D). 
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Fig. 14. Effects ofnomifensine (20 mg/kg; i.p.) on electrochemical responses in the 
nucleus accumbens shell (NacSh) evoked by electrical stimulation of the paraventricular 
nucleus of the thalamus (PVT). Electrical stimulation of the PVT in 5 animals produced a 
transient increase in NacSh oxidation current detected by constant potential 
amperometry. Administration of the dopamine uptake inhibitor nomifensine induced a 
marked increase in the peak of the response evoked by PVT stimulation (A). 
Nomifensine also increased the time required for a response to diminish 80% from its 
peak value (T80, B). Examples from two different animals are shown before (dotted lines) 
and after (solid lines) nomifensine administration (C, D). Timing ofPVT stimulation is 
presented underneath each response (bar). Data was recorded from 5 animals, and 
placements of the stimulating and recording electrodes are shown within the PVT and 
NacSh, respectively (E). Numbers (E) represent approximate distance anterior(+) and 
posterior (-) to bregma. 
*p < 0.05; ***p < 0.001 
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3.4.4 Effect of intra-VTA lidocaine on PVT -evoked oxidation current in the NacSh 
The effect of large injections of lidocaine in the VTA on PVT-evoked responses 
was examined to assess the possibility that PVT stimulation produces dopamine efflux 
via a muti-synaptic excitatory pathway to the VTA. Administration of2 J..Ll of 4% 
lidocaine into the VT A induced a decrease in the resting voltammetric signal in the 
NacSh. This decrease in baseline levels apparent in all4 animals used for data collection 
and suggests successful inhibition of dopaminergic activity. The PVT was stimulated at 
various time points following lidocaine while the oxidation current was monitored in the 
NacSh. The effect oflidocaine was tested up to one hour following administration and 
was found to have no effect on the peak and clearance of PVT -evoked oxidation current 
(Fig. 15 A, B). Tracings showing the evoked signal were strikingly similar before (dotted 
traces, Fig. 15 C, D) and after lidocaine infusion (solid traces, Fig. 15 C, D). Thus, the 
PVT -evoked dopamine response in the NacSh does not appear to be mediated by the 
firing of midbrain dopamine neurons. 
3.4.5 Effect of kynurenic acid on PVT-evoked oxidation current in the NacSh 
Due to the finding that inhibition of midbrain dopamine neurons had no effect on 
PVT-evoked dopamine efflux in the NacSh, it is likely that the effect is due to a 
glutamatergic projection directly from the PVT to the NacSh. To examine the possibility 
that PVT-evoked dopamine release in the NacSh is dependent upon glutamate release in 
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Fig. 15. Effects oflidocaine (2 J.Ll, 4%) injections in the ventral tegmental area (VTA) on 
electrochemical responses in the nucleus accumbens shell (NacSh) evoked by electrical 
stimulation of the para ventricular nucleus of the thalamus (PVT). Lidocaine infusion into 
the VTA failed to diminish peak value (A) and clearance rate (B) of the oxidation current 
in the NacSh evoked by electrical stimulation of the PVT. C, D, Examples from two 
different animals are shown before (dotted lines) and after (solid lines) lidocaine infusion. 
Timing ofPVT stimulation is presented underneath each response (bar). Data was 
recorded from 5 animals, and placements of the stimulating and recording electrodes as 
well as lidocaine infusion sites are shown within the PVT, NacSh, and VTA, respectively 
(E). Numbers (E) represent approximate distance anterior ( +) and posterior (-) to 
bregma. 
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the NacSh, I examined the effect of blocking ionotropic glutamate receptors in the NacSh 
using the broad spectrum glutamate receptor antagonist kynurenic acid. The PVT was 
stimulated before and every 5 minutes after kynurenic acid infusion directly into the 
NacSh. Kynurenic acid (50 m.M, 500 nl) significantly attenuated the size of 
electrochemical responses in the NacSh following PVT stimulation (Fig. 16; F(s, JS) = 
12.78; p < 0.001). Post-hoc comparison (Tukey's) revealed a significant attenuation at 
the 1, 5, and 1 0 minute time points tested following kynurenic application. 
3.4.6 Effect of apomorphine on PVT -evoked oxidation current in the NacSh 
Although kynurenic acid infusion significantly attenuated the PVT -evoked 
electrochemical response, complete blockade was not observed. To further investigate 
any involvement of the dopamine neurons in the VTA, the D1/D2 agonist apomorphine 
was administered (0.15 mg/kg; i.v.) and the PVT was stimulated before and every 5 
minutes after apomorphine injection. At this dose, apomorphine completely inhibits 
dopamine neurons in vivo (Grace & Bunney, 1983), a property reflected in the present 
studies by an observed drop in the resting voltammetric signal following administration. 
Apomorphine, like lidocaine infusion into the VT A, had no effect on oxidation current 
evoked by PVT stimulation (Fig. 1 7). 
Fig. 16. Effects ofkynurenic acid (KA; 500 nl, 50 mM) on electrochemical responses in 
the nucleus accumbens shell (NacSh) evoked by electrical stimulation of the 
para ventricular nucleus of the thalamus (PVT). Kynurenic acid infusion locally within the 
nucleus accumbens attenuated the magnitude ofNacSh oxidation current evoked by PVT 
stimulation (p < 0.01). Responses returned to control values within 30 minutes following 
KA infusion. Infusion of saline into the NacSh had no effect on PVT -evoked dopamine 
events in the NacSh. 
*p < 0.05; **p < 0.01 
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Fig. 17. Effect of apomorphine (0.15 mg!kg, i. v.) on electrochemical responses in the 
nucleus accumbens shell (NacSh) evoked by electrical stimulation of the paraventricular 
nucleus of the thalamus (PVT). Apomorphine did not have any effect on the PVT -evoked 
oxidation currents observed in the NacSh (F(4, t9) = 1.31, p > 0.05). 
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3.4. 7 Relationship between anterograde labeling from the PVT and tyrosine 
hydroxylase immunoreactivity in the NAcSh 
Anterograde tracer deposits restricted to the PVT resulted in dense BDA fiber and 
terminal labeling within the NacSh. Regions ofheavy BDA labeling coincided with 
regions of heavy tyrosine hydroxylase labeling. A representative case is shown where an 
injection restricted to the right of the midline in the anterior PVT (Fig. 18A) resulted in 
dense anterograde labeling in the NacSh ofthe right hemisphere (Fig. 18 B, C). 
As previously reported, tyrosine hydroxylase was observed to have a dense 
heterogeneous distribution within the NacSh compared to the nucleus accumbens core 
and caudate - putamen. This heterogeneous distribution was matched by fibers 
anterogradely labeled from the PVT. Examination at high magnification revealed that the 
dense plexus ofBDA fibers overlapped regions ofhigh tyrosine hydroxylase 
immunoreactivity while avoiding the tyrosine hydroxylase poor areas in the NacSh (Fig. 
18 C). Injections ofBDA in the anterior PVT resulted in this type oflabeling in the 
dorsomedial and ventromedial shell whereas injections in the posterior PVT produced 
this pattern in the ventromedial and ventrolateral shell. 
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Fig. 18. Projections from the paraventricular nucleus of the thalamus (PVT) overlap with 
tyrosine hydroxylase immunoreactivity within the nucleus accumbens shell (NacSh). 
Biotin dextran amine (black, BDA) iontophoresis into tQ.e PVT (A) resulted in fiber 
labeling in the NacSh (B, C). Heavy regions ofBDA labeling coincide with dense 
tyrosine hydroxylase activity (brown). 
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3.4.8 Effect of PVT stimulation on oxidation current throughout the striatum 
Oxidation currents were monitored throughout two dorsal-ventral tracts in the 
striatum while a brief stimulation was applied to the PVT (Fig. 19). PVT -evoked 
oxidation current increases were noted for every case in which the recording electrode 
was in the NacSh. Recording sites in the lateral septum located dorsally to the NacSh 
generated no current change upon PVT stimulation but responses appeared and gradually 
increased in magnitude as the recording electrode was moved ventrally into the NacSh. 
For the lateral tract, no response could be seen in the dorsal striatum while a moderate 
response could be found when the electrode was lowered into the core of the nucleus 
accumbens. The oxidation currents were monitored in different regions throughout the 
striatum while the PVT was stimulated at different current intensities. PVT -evoked 
responses could only be seen in the NacSh when the PVT was stimulated at 150 flA. At 
this current intensity, no response was seen in the septum, dorsal striatum or nucleus 
accumbens core. The response in the NacSh could no longer be observed when the PVT 
was stimulated using currents less than 150 flA. 
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Fig. 19. The paraventricular nucleus ofthe thalamus (PVT) was stimulated (400 J.I.A; 1.0 
mm pulses at 40Hz for 5s) while a carbon fiber electrode was adjusted to recorde 
dopamine oxidation currents in various striatal regions. Stimulation of the PVT increased 
electrochemically detected dopamine in the nucleus accumbens shell (NacSh) and, to a 
lesser degree, in the nucleus accumbens core (NacC). PVT stimulation had no effect on 
oxidation currents dorsal to the NacSh or in the dorsal striatum. Response magnitude 
was the greatest for placements in the NacSh. aca, anterior commissure; CPu, caudate-
putamen. 
89 
2.~ 
3.~ 
4.~ 
s. (\ ~L 
_j~ 
6.~ 
8.~ 
9.~ 
+1.50 mm 
3.5 Summary 
From the results of the present studies, it is suggested that the PVT is unique in that 
it receives numerous overlapping signals from hypothalamic peptides such as the orexins 
and CART. Regions of heavy orexin and CART innervation within the midline and 
intralaminar thalamus coincide with a dense population of PVT neurons projecting to the 
NacSh. Stimulation of the PVT results in a brief increase in electrochemically-detected 
dopamine release in the NacSh and is unaffected by the inhibition of midbrain dopamine 
neurons. However, PVT -evoked dopamine efflux in the NacSh is attenuated following 
intra-accumbens infusions of the ionotropic glutamate receptor antagonist kynurenic acid, 
suggesting that the response is mediated by glutamate release from PVT terminals within 
the NacSh. This is likely to occur via activation of glutamate receptors located on 
dopamine terminals in the NacSh. The proposed mechanism for a PVT influence on 
NacSh dopamine release can be seen in Figure 20. 
91 
Fig. 20. Schematic diagram demonstrating a likely mechanism by which stimulation of 
the para ventricular nucleus of the thalamus (PVT) results in a transient increase in 
dopamine oxidation current within the shell of the nucleus accumbens (NacSh). This 
proposal suggests that glutamate released from PVT terminals can activate glutamate 
receptors that are located on dopamine terminals within the NacSh. Although the 
dopaminergic innervation ofthe NacSh originates from neurons in the VTA, inhibition of 
VTA dopamine neurons had no effect upon PVT-evoked dopamine release in the NacSh. 
Rather, blockade of ionotropic glutamate receptors in the NacSh attenuated the increase 
in dopamine oxidation current evoked by PVT stimulation. It is suggested that the PVT 
can presynaptically modulate dopamine release in the NacSh by an impulse-independent 
mechanism. 
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4.1 Anatomical Experiments 
4.1.1. Orexin and CART innervation of the midline and intralaminar thalamus 
Immunohistochemistry throughout the PVT revealed that orexin and CART 
peptide fibers heavily innervate the PVT while adjacent thalamic nuclei receive a 
relatively weak innervation from these peptides. Both fiber types largely avoided the 
mediodorsal nucleus and the habenular complex as well as the sensory relay thalamic 
nuclei. These observations provide the most detailed description of orexin and CART 
innervation of the midline and intralaminar nuclei to date. Multi-label 
immunofluorescence with confocal microscopy further revealed that synaptophysin, a 
marker indicative of presynaptic release, was co-localized on numerous orexin- and 
CART-positive enlargements. Consistent with these results, a strong signal for orexin 
receptor mRNA is found in the PVT (Marcus et al., 2001) and PVT neurons are excited 
by orexin in vitro (Ishibashi et al., 2005). However, receptors for the CART peptide have 
yet to be identified and no study has looked at the effects of CART peptide application on 
the firing of PVT neurons. While the co-localization of these peptides and synaptophysin 
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are indicative of release sites, confirmation of these observations at the ultrastructural 
level are necessary to provide definitive evidence for presynaptic release of orexin and 
CART in the PVT. Nonetheless, electron microscopy has confirmed that both peptides 
are packaged in large dense-core vesicles within separate presynaptic sites suggesting 
that they can be released in the synaptic cleft to influence the postsynaptic neuron (Smith 
eta/., 1999). 
4.1.2. Orexin and CART fibers in relation to PVT neurons projecting to the NacSh 
Retrograde labeling from the NacSh established that orexin and CART fiber 
innervation of the PVT heavily overlaps thalamic neurons projecting to the NacSh. High 
magnification light and confocal imaging techniques provide evidence supporting the 
existence of orexin and CART fiber contacts onto PVT neurons projecting to the NacSh. 
Although a large number of neurons in the paratenial nucleus were labeled following 
tracer injections in the NacSh, this thalamic nucleus contains very weak orexin and 
CART immunoreactivity. Therefore, the PVT is the only nucleus of the thalamus to 
receive both orexin and CART afferent input and to project to the NacSh. The retrograde 
tracer injections into the NacSh varied along its anteroposterior axis to cover the entire 
NacSh and the resulting retrograde labeling in the thalamus was similar for all ten 
subjects regardless of whether FG or CTb was used. Labeled neurons were observed in 
the anterior, middle and posterior PVT, with the most pronounced cluster of retrogradely 
labeled cells location in more posterior sections. 
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As mentioned. immunoreactivity for orexin. CART and PVT cells retrogradely 
labeled from the NacSh was observed throughout the entire PVT. Investigation at high 
magnitication revealed putative contacts between both orexin and CART fibers and PVT 
neurons projecting to the NacSh throughout the anterior, middle, and posterior PVT. The 
presence of these contacts did not seem to depend on the anteroposterior placement of the 
tracer injection within the NacSh. Numerous appositions were observed throughout the 
50 !J.m depth of sections which were stained histochemically with DAB and examined 
with the light microscope. Although this gives a good understanding of the density of the 
tiber innervation, light microscopy cannot be used as conclusive evidence for synaptic 
contact. The confocal microscope was used to provide stronger evidence by ensuring that 
the observed contacts were within the same plane as the labeled neuron. In fact 
numerous appositions could be seen when tissue was scanned at 0.4 !J.m intervals. It was 
also demonstrated that a majority of orexin and CART fiber enlargements in the PVT co-
express immunoreactivity for the synaptophysin protein. Synaptophysin is a protein 
involved in presynaptic vesicle release and its frequent co-localization with orexin and 
CART fiber varicosities indicate that the appositions observed in the present experiments 
are likely to contain sites of presynaptic release. Although the confocal microscope is a 
useful tool for the visualization of spatial interactions between fibers and cells of interest, 
electron microscopy is necessary to fully understand the synaptic nature of these 
elements. However, confocal imaging proved to be the more suitable choice due to the 
relative ease of multi-labeling and the ability to sample a larger area of tissue. 
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Both FG and CTb failed to completely till PVT neurons. Contacts could only be 
noted for those immunopositive regions of the cell body and most proximal region of 
dendrites. Interestingly, more complete cellular staining was evident for retrogradely 
labeled paratenial cells in anterior thalamic sections. Both CTb and FG tracers are 
capable of providing complete neuronal staining, a property that unfortunately does not 
seem to apply to all cell groups. Slight alterations in injection parameters, recovery time, 
fixation and incubation time did not seem to produce completely stained neurons within 
the PVT. To overcome this, neurobiotin was infused directly into the PVT to completely 
till the soma and proximal dendrites of PVT neurons. Distal dendrites could be seen 
under the fluorescence microscope but were not able to be picked up by the confocal 
microscope. In my experience. it seemed that the t1uorescence microscope was more 
sensitive than the confocal microscope. Perhaps this is due to the imaging of the entire 
section depth combined with a wide wavelength employed to excite the fluorophore of 
interest. On the other hand. confocal microscopy generates thin optical sections and uses 
very strict emitted wavelengths to excite the fluorophore and may contribute to the slight 
sensitivity disadvantage of the confocal microscope. Nonetheless, when combined with 
orexin or CART immunofluorescence, frequent fiber contact onto the proximal dendrites 
ofPVT neurons could be seen. For the majority ofPVT neurons scanned, neuropeptide 
contacts onto proximal dendrites were just as common as axosomatic appositions. It is 
concluded that orexin and CART fibers innervate both the soma and proximal dendrites 
ofPVT neurons projecting to the NacSh. Unfortunately, it could not be concluded 
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whether there are axodendritic contacts on distal dendrites due to the aforementioned 
problem of labeling distal dendrites. 
4.1.3. The PVT as a site of integration of competing signals 
An interesting finding is that individual PVT neurons were typically apposed by 
both the orexin and CART fiber types. The orexins have been shown to frequently co-
localize with glutamate, form asymmetric synapses, and have an excitatory e±Iect at the 
postsynaptic neuron (Ishibashi eta!., 2005; Torrealba eta!., 2003). Conversely, CART 
has been shown to frequently co-localize with GABA, form symmetric synapses, and 
have inhibitory effects at the postsynaptic neuron (Smith eta!., 1999; Yermolaieva eta!., 
2001 ). The finding that both of these peptide fibers make putative contact onto the same 
PVT neuron with a known projection to the nucleus accumbens suggests an important 
role for the PVT in the integration of hypothalamic and brainstem activity. The PVT may 
act to integrate competing signals from numerous regions and then relay this information 
to the NacSh. The idea that orexin and CART activity within the PVT would compete to 
influence PVT neurons activity is supported by research demonstrating an opposite effect 
of the orexin and CART peptides on food intake. For example, central administration of 
orexin promotes food intake while CART peptide application inhibits food intake 
(Sakurai eta!., 1998; Vrang eta!., 1999). Interestingly, co-application of both orexin and 
CART was shown to result in feeding behavior identical to that of controls (Volkoff & 
Peter, 2000). Furthermore, food deprivation up-regulates orexin mRNA and down-
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regulates CART mRNA (X. J. Cai et al .. 1999; Kristensen et al., 1998). Both orexin and 
CART neurons co-express immunoreactivity for leptin receptors, and leptin is suggested 
to have opposite etTects on the production and release of the two peptides (Elias eta/., 
2001: Hakansson et al., 1999; Lopez eta/., 2000). Not only does the PVT receive 
innervation from the orexins and CART. other peptides and monoamines such as alpha-
MSH, neuropeptide Y, norepinephrine and serotonin are likely to converge within the 
PVT and collectively affect the activity of PVT neurons. 
4.2. Voltammetry Experiments 
The voltammetry experiments show that phasic activation of the PVT produced 
an increase in oxidation currents recorded in the NacSh. A dopaminergic identity of the 
evoked oxidation currents is indicated by the property of the nation-coated carbon fiber 
electrodes, the observed red/ox ratios and relative concentration of competing molecules 
within the NacSh, and the changes in electrochemical responses induced by 
pharmacological manipulation. Electrical stimulation of thalamic nuclei adjacent to the 
PVT did not produce oxidation currents in the NacSh indicating that the evoked oxidation 
currents were unique to activation of the PVT. The present study also shows that the 
transient increases in oxidation currents in the NacSh were attenuated upon intra-
accumbens infusion of the general ionotropic glutamate receptor antagonist kynurenic 
acid but remained unaffected by treatments eliminating the influence of dopamine neuron 
activity. These results suggest that the PVT can influence dopamine release at the 
99 
terminal site and are consistent with a similar mechanism of dopamine modulation 
reported for other limbic inputs to the NacSh (Blaha eta/., 1997; Floresco eta/., 1998; 
Howland et a/., 2002). 
4.2.1. Electrochemical Specificity 
Increases in oxidation current within the NacSh were detected using carbon fiber 
electrodes which were determined prior to experimentation to have a high selectivity 
favoring dopamine over ascorbic acid and DOPAC. The negatively-charged nation 
coating on each electrode prevented current changes due to the oxidation of these anionic 
interferents. Selectivity was quantified by adding 2.5 J..I.M of dopamine to a beaker and 
comparing the response to additions of250 J..I.M ofboth ascorbic acid and DOPAC. If 
necessary, additional nation coatings were applied until the electrode demonstrated at 
least a 100:1 selectivity for dopamine over both ascorbic acid and DOPAC. Furthermore, 
the extracellular concentrations of these interferents are likely to remain at relatively 
stable levels over short periods of time and are unlikely to be involved in the transient 
responses measured in our experiments. Another important issue in terms of selectivity is 
the possibility that changes in norepinephrine and serotonin, two other monoamines that 
are found in lower concentrations in the NacSh (Allin eta/., 1988; Versteeg eta/., 1976), 
could be responsible for the observed oxidation currents following activation of the PVT. 
Successful chronoamperometric recordings were obtained from a few active sites and a 
red/ox ratio between 0.7 and 0.8 was observed throughout the duration ofPVT-evoked 
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responses. This red/ox value is indicative of dopamine and not norepinephrine (red/ox = 
0.08 - 0.28; Gerhardt & Hoffinan, 2001) or serotonin (red/ox = 0.13 - 0.19; Gerhardt & 
Hoffman, 2001 ). Discussions on use of chronoamperometry have been published 
previously (Blaha & Phillips, 1996; Gerhardt & Burmeister, 2000) and this method has 
been widely used to measure dopamine in the nucleus accumbens. Anatomically, a 
response was only found upon PVT stimulation when the recording electrode was in a 
region receiving PVT and tyrosine hydroxylase innervation. Responses could not be 
observed when the electrode was moved from the NacSh to the adjacent vertical limb of 
the diagonal band of Broca, a region devoid of tyrosine hydroxylase immunoreactivity. 
The observation that administration of the dopamine uptake inhibitor nomifensine 
increased the peak and slowed reuptake of PVT -evoked electrochemical responses in the 
NacSh is also consistent with the signal representing an evoked dopamine efllux. 
Together, these data suggest that the increase in oxidation current in the NacSh in 
response to PVT stimulation represents an increase in dopamine concentration. 
4.2.2. Mechanism of PVT -evoked dopamine release in the NacSh 
Although the PVT is anatomically positioned to influence dopamine levels via 
multiple pathways, the present data indicate that the PVT -evoked response is independent 
of dopamine cell firing. The PVT sends a dense projection to the NacSh and the 
prefrontal cortex (Bubser & Deutch, 1998; Moga eta/., 1995; Otake & Nakamura, 1998; 
Van der Werf eta/., 2002), and both of these regions have direct and indirect projections 
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to dopamine neurons within the VTA (Geisler & Zahm, 2005; Zahm, 2000; Zahm & 
Heimer, 1990; Zahm et a/., 1996). Infusion of lidocaine into the VT A or systemic 
administration of apomorphine, two treatments that inactivate dopamine neurons in the 
midbrain, had no effect on the PVT -evoked responses. This is consistent with studies 
showing that dopamine release evoked by stimulation of the ventral subiculum of the 
hippocampus or basolateral nucleus of the amygdala, both of which send a glutamatergic 
projection to the NacSh, could not be attenuated by inhibiting dopamine cell activity 
(Blaha et al., 1997; Floresco eta/., 1998; Howland eta/., 2002). In the present 
experiments, large decreases in the resting oxidation current were observed in the NacSh 
following the intra-VTA injections of lidocaine and the systemic injections of 
apomorphine. This baseline drop is indicative of successful dopamine neuron inhibition 
and is consistent with previously reported electrochemical reactions to similar treatments 
(Floresco et a/., 1998; Howland et a/., 2002). The PVT -evoked oxidation currents in the 
NacSh remained clearly unaffected by lidocaine and apomorphine indicating that the 
evoked responses were not mediated by changes in the activity of midbrain dopamine 
neurons. 
Dopamine regulation by limbic afferents to the NacSh has been shown to depend 
largely on glutamate receptors within the striatum (Blaha eta/., 1997; Floresco eta/., 
1998; Howland et al., 2002). Although dopamine and glutamate terminals have not been 
observed to form axo-axonic synapses, numerous PVT terminals have been shown to 
appose dopamine terminals within the NacSh (Pinto eta/., 2003). The presence of 
NMDA receptors on dopamine axons (Gracy & Pickel, 1996) suggests that glutamate 
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release from PVT terminals can influence dopamine release at the presynaptic level. 
Reports of the effects of glutamate agonists on local striatal dopamine release are 
inconsistent; the observed response being dependent on injectate concentration and 
volume as well as the pipette/electrode tip distance (David et al., 2005; Morari et al., 
1998; Whitton, 1997). Despite these inconsistencies, several studies have shown that 
infusion ofhigh concentrations ofNMDA, AMPA, or kainate directly into the striatum 
can elicit local dopamine release (Carrozza et al., 1992; Keefe et al., 1992, 1993; 
Martinez-Fong et al., 1992; Sakai et al., 1997; Smolders et al., 1996). In the present 
.. , .. 
study, a significant attenuation ofPVT-evoked responses in the NacSh was seen 
following intra-accumbens infusion of the glutamate receptor antagonist kynurenic acid, 
suggesting that glutamate release from PVT terminals acts on glutamate receptors within 
the NacSh to trigger dopamine release. The frequent appositions between PVT and 
tyrosine hydroxylase fibers as well as the observed attenuation of PVT -evoked oxidation 
currents following local glutamate receptor antagonism suggests that glutamate release 
from PVT terminals is involved in the presynaptic regulation of dopamine. 
The observed attenuation is believed to result from antagonistic actions at 
glutamate receptors within the vicinity of the recording electrode. Infusion of both saline 
and kynurenic acid dissolved in saline resulted in a brief decrease of the voltammetric 
signal. This baseline drop cannot be attributed to the electrode's response to kynurenic 
acid itself, as there was no response to kynurenic acid additions in vitro during pre-
calibration. Furthermore, the drop cannot be attributed to the pharmacological actions of 
kynurenic acid as the same decrease was observed upon saline administration. This 
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suggests a dilution of resting dopamine levels near the recording electrode rather than a 
decrease in dopamine tone itself. Dilution of the analyte as a result of local drug 
administration has been previously reported (Blaha eta/., 1997; Floresco eta/., 1998; 
Blaha & Phillips; 1996) and intra-striatal infusions of kynurenic acid has been shown to 
have no effect on dopamine levels (Keefe eta/., 1993). There were a few cases in which 
this decrease was not apparent, and were later shown histologically to be due to a 
distance greater than 600 !J.m between the tips of the infusion pipette and recording 
electrode. A lateral distance of approximately 500 !J.m has been reported to be the limit of 
neuronal inactivation following GABA injection into the visual cortex (Hupe et a/., 
1999). According to this, injection volumes used in the present study would not be able to 
overcome a large separation between the pipette and electrode tips. Therefore, if a 
baseline drop is not observed upon local drug infusion, it is likely that the volume did not 
reach the immediate area of the recording electrode and cannot exert its pharmacological 
actions at that site. Not surprisingly, if a baseline drop was not apparent in the present 
study, the treatment seemed to have no effect on the properties ofPVT-evoked responses. 
These cases were subsequently dropped from data analysis. PVT -evoked responses were 
attenuated in all subjects responding initially to kynurenic acid infusion with a small 
decrease in baseline. Although the same baseline drop was observed upon saline infusion, 
saline alone had no effect on PVT -evoked dopamine responses. 
The precise mechanism by which glutamate release from PVT terminals in the 
NacSh might regulate dopamine release locally remains to be determined. First, the 
release of glutamate by phasic activation of the PVT may depolarize dopamine terminals 
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by acting on ionotropic receptors located on the dopamine fiber resulting in Ca++ influx 
and release of dopamine. Second, cholinergic nicotinic receptors found on dopamine 
fibers in the striatum (I. W. Jones eta/., 2001) have been shown to regulate striatal 
dopamine release (Fu et a/., 2000; Fung, 1989; Zhou et a/., 2001 ). PVT fibers have been 
shown to innervate cholinergic intemeurons in the NacSh (Meredith & Wouterlood, 
1990) and provides another mechanism by which glutamate afferents to the NacSh may 
regulate local dopamine release. Third, a recent in vivo experiment provides evidence for 
glutamate to act locally on ionotropic receptors in the striatum to maintain tonic levels of 
dopamine by a reverse transport mechanism mediated by the dopamine transporter 
(Borland & Michael, 2004). In this case, dopamine release would occur via activation of 
reverse transport of dopamine and not from release from synaptic vesicles (Leviel, 2001 ). 
However, PVT-evoked dopamine release in the NacSh in the present experiments is not 
likely due to a reverse transport mechanism because systemic administration of the 
dopamine uptake inhibitor nomifensine did not attenuate the PVT evoked responses. 
Nonetheless, the exact mechanism by which glutamate release from PVT terminals elicits 
dopamine release in the NacSh remains to be determined. 
4.2.3. Differential regulation of dopamine release in the heterogeneous NacSh 
The conclusion that PVT stimulation evokes dopamine efflux in the NacSh is 
further supported by the relationship observed between the recording electrode 
placements in the striatum and the magnitude of the response recorded from stimulation 
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of the PVT. Stimulation of the PVT produced the largest oxidation currents when the 
recording electrode was placed in the NacSh. Consistent with previous anterograde and 
retrograde tract tracing studies (Berendse & Groenewegen, 1990; Moga eta/., 1995; Su 
& Bentivoglio, 1990), I found that the PVT sends a dense projection to the NacSh and a 
moderate projection to the core of the nucleus accumbens. Therefore, it is especially 
striking that stimulation of the PVT evoked the largest oxidation current responses in the 
NacSh whereas only moderate responses could be elicited in the core. The PVT does not 
provide input to the rest of the dorsal striatum and no oxidation current responses were 
observed in the dorsal striatum upon PVT stimulation. However, other midline and 
intralaminar thalamic nuclei provide inputs to different subregions of the striatum 
(Groenewegen & Berendse, 1994). Even though I did not examine the effects of 
stimulation of adjacent thalamic nuclei, it is possible that these areas of the thalamus can 
modulate dopamine levels in regions of the dorsal striatum. 
The present data demonstrate that the tyrosine hydroxylase staining has a 
heterogeneous distribution in the NacSh and that the PVT preferentially innervates the 
regions of dense staining. This is consistent with other anterograde studies showing that 
the PVT projections to the NacSh targets areas moderately stained for enkephalin 
(Berendse & Groenewegen, 1990), the same areas which receive a dense dopaminergic 
innervation (V oom eta/., 1986). Although PVT stimulation typically resulted in an 
oxidation current increase in the NacSh corresponding to dopamine levels in the 
magnitude of 40 - 50 nM, a few cases were observed in which these transients peaked 
upwards of 200 nM. Therefore, it is possible that sites that gave the largest responses 
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may have resulted from voltammetry recordings in regions receiving a very dense 
dopamine and PVT fiber innevation. It is also of interest that the regions of the NacSh 
containing dense dopamine and PVT inputs correspond to the same regions that receive 
afferents from the ventral subiculum (Groenewegen eta/., 1987). Areas of the NacSh 
with weak dopamine immunoreactivity and avoided by PVT afferents receive inputs from 
the basolateral nucleus of the amygdala and the medial prefrontal cortex (Wright & 
Groenewegen, 1995). Each ofthese sub-territories appears to have unique set of 
dopamine receptors, neurotransmitters and projection targets (Heimer eta/., 1997). 
Consequently, differential regulation of dopamine release within these sub-regions by 
specific glutamatergic inputs may have different physiological functions. The extent and 
significance of differential regulation of dopamine release within sub-territories of the 
NacSh may be helpful in providing a better understanding of the role of dopamine in the 
NacSh. 
4.2.4 Dopamine release and NacSh output 
The consequence of increased dopamine efflux within the NacSh is difficult to 
interpret, given the interactions between dopamine itself and glutamatergic afferents from 
the prefrontal cortex, amygdala and hippocampus. Nonetheless, dopamine application to 
nucleus accumbens slices has been shown to increase spike frequency in medium spiny 
neurons and this effect is dependent upon activation ofboth Dl and D2-like receptors 
(Hopf eta/., 2003). Furthermore, dopamine was found to decrease glutamate release 
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through activation ofD2-Iike receptors located presynaptically whereas infusions ofD1 
receptor antagonists had no effect on glutamate release within the accumbens (Maura et 
at., 1988; Yamamoto & Davy, 1992). It is likely that the PVT-evoked dopamine release 
observed in the present studies may affect behavioral output by increasing the activity of 
medium spiny output neurons of the NacSh via co-activation ofD1 and D2 receptors on 
the postsynaptic neuron as well as through presynaptic inhibition of glutamate release. 
4.3. Significance 
The anatomical data provide evidence that orexin and CART neuropeptides can 
influence the nucleus accumbens using the PVT as a site of integration and relay. 
Although the current work concerns orexin and CART fibers in the PVT, several other 
neuropeptides have been reported to heavily innervate the PVT (Freedman & Cassell, 
1994; Otake & Nakamura, 1995). This places the PVT in an anatomical position to 
receive convergent information from hypothalamic neuropeptides and brainstem 
monoamines and then integrate and relay this activity to the nucleus accumbens, an area 
of the striatum involved in motivational responding and behavioral activation. 
The voltammetry experiments demonstrate that the PVT plays a role in the 
modulation of tonic dopamine tone in the NacSh. In addition to the PVT, the NacSh 
receives glutamatergic inputs from the ventral subiculum of the hippocampus, 
basaolateral nucleus of the amygdala and medial prefrontal cortex. These convergent 
glutamate afferents have been shown to influence dopamine release in the NacSh (Blaha 
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et al., 1997; Floresco et al., 1998; Howland et al., 2002) and interaction between these 
inputs is likely to play an important role in overall dopamine regulation and therefore the 
selection and initiation ofbehavioral activity (Groenewegen et al., 1987; Mogenson et 
al., 1980; Mogensen & Yang, 1991 ). The PVT, by receiving afferents from hypothalamic 
peptides such as orexin and CART as well as from numerous brainstem arousal nuclei 
(Freedman & Cassell, 1994; Kirouac et al., 2005; Otake, 2005; Otake et al., 2002; Otake 
& Ruggiero, 1995; VanderWerf et al., 2002), is highly responsive to stress and arousal 
(Bubser & Deutch, 1999; Otake et al., 2002; Peng et al., 1995). Interestingly, dopamine 
levels in the nucleus accumbens peak during periods of active waking (Castaneda et al., 
2004; Lena et al., 2005) and increase dramatically during periods associated with stress 
(Kalivas & Duffy, 1995; Stevenson et al., 2003). A similar pattern of activity is observed 
in the PVT in that expression of c-fos mRNA and c-Fos protein is enhanced during 
periods of active waking and greatly increased following exposure to a stress protocol 
(Bubser & Deutch, 1999; Otake et al., 2002; Sica eta/., 2000; Timofeeva & Richard, 
2001 ). This is the first report demonstrating an influence of the PVT on tonic dopamine 
levels in the striatum. While speculative at this point, arousal related activation of the 
PVT may be important for motivation through an arousal-based maintenance or stress-
induced increase of tonic dopamine levels in the NacSh (Blackburn eta/., 1992; Horvitz, 
2000; Salamone & Correa, 2002). 
Overall, the present thesis demonstrates that orexin and CART peptide fibers 
appose PVT neurons projecting to the NacSh and that PVT stimulation can influence 
levels of extrasynaptic dopamine release within the NacSh. Although the PVT receives a 
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wide variety of arousal-related afferent inputs, numerous peptides projecting to the PVT 
are involved in food intake. It can be proposed that this hypothalamic-thalamic-striatal 
projection functions in part to regulate motivated behavior related to feeding. As 
mentioned in section 1.3, intracerebroventricular application of the orexin and CART 
neuropeptides dramatically influence food intake, and food deprivation or overfeeding 
regulates the expression of mRNA encoding these peptides. The PVT is also heavily 
innervated by other hypothalamic peptides involved in energy homeostasis such as 
neuropeptide Y, cholecystokinin, agouti related peptide and alpha-MSH (Freedman & 
Cassell, 1994). The present thesis also demonstrates that the same PVT neuron is 
frequently innervated by both orexin and CART peptide fibers. The heavy innervation of 
the PVT by other hypothalamic peptides raises the possibility that a given PVT neuron is 
innervated by a number of signals representing energy balance. It is not surprising that 
PVT lesions influence both food intake and anticipatory reactions to an expected food 
reward (Bhatnagar & Dallman, 1999~ Nakahara et al., 2004). By demonstrating that the 
PVT has a glutamate-dependant presynaptic influence on tonic dopamine levels in the 
NacSh, it is likely that energy homeostatic signals represented in the PVT are transmitted 
to the NacSh where dopamine levels are altered accordingly to initiate an appropriate 
behavioral response. A number of studies suggest that dopamine levels in the NacSh are 
not implicated in the reward value of a food reward, rather demonstrating a dopaminergic 
role in the initiation of a consummatory response. Salamone (Salamone et al., 2003) 
argues that nucleus accumbens dopamine is critical to the initiation of energy expenditure 
to obtain food reward in an instrumental learning paradigm, a theory consistent with the 
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association between the NacSh and motivation. In agreement, others have raised the 
notion that accumbens dopamine is not involved in the primary reinforcing properties of 
food reward ("liking") but rather in aspects of incentive salience ("wanting"). This is 
well observed in studies using a choice test in which rats can either lever press for a 
preferred food reward or simply consume, without any lever pressing, a less desirable 
food. A variety of dopamine antagonists, administered either systemically or locally 
within the accumbens, has been shown to substantially reduce the probability that an 
animal will exert effort to obtain the preferred reward (Koch et al., 2000; Salamone & 
Correa, 2002). Further support for an accumbens/dopamine role in the initiation of 
feeding arises from voltammetric recordings of behaving animals. By monitoring 
dopamine oxidation currents within the NacSh on a subsecond timescale, Roitman eta/., 
(2004) demonstrated that when a salient cue was paired with subsequent food reward, 
dopamine effiux was observed immediately following the cue and prior to the 
presentation and receipt of the reward. These data suggest that tonic dopamine increases 
within the NacSh play a role in food-seeking behavior and is consistent with a 
hypothalamic-thalamic-striatal circuit involved in initiating appropriate behavioral 
responses to homeostatic challenge. 
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